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ABSTRACT 
 
The experiment investigated supplementation of maternal metabolizable protein in an 
isocaloric diet during late gestation on fetal organ growth and skeletal muscle development in 
sheep. Although fetal body weight was unaffected by treatment, visceral organ weights were 
sensitive to MP treatment as alterations in small intestinal mass and perirenal adipose tissue 
content suggest impacts on postnatal growth. Two-dimensional gel electrophoresis and mass 
spectrometry compared the sarcoplasmic and myofibrillar protein fractions of fetal skeletal 
longissimus muscle, identifying spots from the sarcoplasmic and myofibrillar protein fractions 
(30 and 12, respectively). Increased expression of fructose-bisphosphate aldolase in fetal muscle 
from protein-supplemented and protein-restricted ewes when compared to those from control 
ewes suggests a positive influence on rate of glycolysis and muscle turnover in these offspring. 
Further research on maternal supplementation with metabolizable protein in isocaloric diets is 
needed to improve fetal growth efficiency, thereby optimizing offspring performance. 
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CHAPTER 1. INTRODUCTION AND LITERATURE REVIEW 
Introduction 
Sheep and lamb inventory in the United States on January 1, 2012, totaled 5.35 million, 
down 2 % from 2011 [National Agriculture Statistics Service (NASS), 2012]. The quality of the 
livestock operations producing these animals has been collectively determined by each 
producer’s reproductive, nutritional, and rangeland management practices. Current sheep 
research has focused primarily on increasing lamb production by increasing the number of lambs 
born per ewe. The 2011 lamb crop of 3.51 million head had a lambing rate of 109 lambs per 100 
ewes one year or older, and this percentage continues to increase (NASS, 2012). 
Past studies conducted in early-life nutrition in sheep began in the 1970s and were 
focused on the early neonatal period and the latter part of pregnancy. These periods were 
selected due to the fact that the nutrient demands on the fetus are highest at these times 
(Robinson et al., 1983). Offspring born to ewes undernourished during late pregnancy produce 
fewer lambs during their adult life because those offspring have a lower incidence of twin lambs 
(Gunn et al., 1995; Rhind et al., 1998). These observations indicate that one or more 
physiological mechanisms are affected by the nutritional state of the offspring during late fetal 
development. Information concerning the underlying mechanisms that encourage muscle growth 
and nutrient utilization in large animal species are largely lacking. We are especially concerned 
with factors that limit fetal growth in sheep because in the field, neonatal mortality rates are high 
in lambs having birth weights below breed averages (Purser et al., 1959; 1964; Alexander, 1974). 
Previous work by Barcroft (1946) found fetus variation in length and weight is proportionately 
greater at birth than at any other stage of pregnancy, indicating that much of this variability can 
be explained by different levels of maternal nutrition during late gestation (Wallace, 1948; 
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Thomson, 1959; Russell et al., 1968; Alexander, 1974). A better understanding in this regard 
provides a means to maximize livestock productivity while improving animal health and 
wellness.  
The most important factor effecting success of most commercial sheep operations is 
reproductive efficiency (Lupton, 1998), defined as the BW of the lamb weaned or marketed per 
ewe exposed. Sheep are raised for food and fiber, and while reproductive efficiency is very 
important, it is also one of the most difficult factors to improve. With profit margins continuing 
to decrease, an increased effort has been placed on maximizing lamb viability (NASS, 2012).  
Current agricultural production goals have focused on the need for energy conservation 
and improved efficiency of economic resources. Currently, the sheep industry is focused on 
increasing the number of lambs per ewe while improving the growth efficiency of those 
offspring. New advancements in animal science research offer the possibility for significant 
improvements in efficiency of meat and fiber production from sheep. 
 Maternal Nutritional Status 
Maternal nutrition during pregnancy has a critical role in the regulation of placental-fetal 
development and thereby affects the lifelong health and productivity of offspring (Belkacemi et 
al., 2010). The dam must alter the partitioning of available nutrients to allow for maintenance of 
her own body tissues and the increasing demand for micronutrients by the gravid uterus. The 
major challenge pregnant ewes must overcome is providing adequate energy and protein to 
support embryonic and fetal growth, maintenance of the animal’s physiology needs, mammary 
gland growth, colostrum and milk yield (Amanlou et al., 2010). Suboptimal maternal nutrition 
can result in low birth weight, with considerable effect, on perinatal morbidity and mortality of 
the newborn.  
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Pregnancy nutrition and its impact on offspring growth and performance have become 
increasingly prominent over the past decade. Maternal nutrition status is an important factor 
associated with nutrient partitioning and eventually the growth and development of major fetal 
organ systems (Wallace, 1948; Wallace et al., 1999; Godfrey and Barker, 2000; Wu et al., 2006; 
Caton et al., 2009, Caton and Hess, 2010). Mature body size of an ovine breeding female can 
range from less than 40 kg to more than 130 kg, having a major influence on total nutrients 
required and on adaptations to various conditions (NRC, 2007). There is a substantial increase in 
nutrient requirements for the late pregnant ewe compared with maintenance (Table 1.1). 
One of the most essential nutrient requirements for both a pregnant ewe and her growing 
fetus is that of protein. Protein supplementation during late gestation is a common management 
practice for maintaining dam body condition score (BCS) and has been shown to enhance 
reproductive success of heifer calves (Martin et al., 2007) and increase weaning weight of steer 
calves (Stalker et al., 2006). 
It appears that restricting maternal protein in late gestation has a greater impact on ewe 
weight than restricting energy. Hoaglund et al. (1992) used 30 Targhee ewes in an experiment 
investigating protein and energy supplementation. In the study, ewes were offered either no 
supplement, soybean meal (to meet ruminal protein needs), or blood meal + soybean meal (to 
provide additional protein above needs throughout gestation). The ME treatments provided either 
80% or 100% of ME requirements during gestation. The group was also offered ad libitum 
access to long-stem barley straw. Ewes fed either of the protein supplementation treatments 
gained more weight and lost less body condition when compared to that of the unsupplemented 
ewes. There was no effect of ME intake on ewe BW or BCS, suggesting that protein may be 
more limiting than energy. 
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Table 1.1. Recommended nutrient intakes and dietary nutrient content for a mature 70-kg ewe 
at various physiological states
1
 
Physiological State 
Energy 
concentration 
in diet  
Dry matter
2
 ME
3
 MP
4
 
 
Kcal/kg kg/d Mcal/d g/d 
Maintenance 1.91 1.68 2.25 60 
Gestation, Early 
(Single lamb; BW = 
3.9 to 7.5 kg) 
1.91 2.09 2.80 81 
Gestation, Late   
(Single lamb; BW = 
3.9 to 7.5 kg) 
1.91 2.58 3.45 105 
1
Adapted from NRC, Nutrient Requirements of Sheep, 2007. 
2
The daily dry matter intake, expressed as kg, of a diet having the indicated energy 
concentration (previous column) that is required to meet energy requirements. 
3
Energy requirements expressed as metabolizable energy (ME) as kcal/d. 
4
Protein requirement expressed as metabolizable protein (MP). 
 
Fetal programming, also known as developmental programming or the Barker hypothesis, 
is based on epidemiological data that show that low birth weight due to maternal malnutrition 
has long-term effects on adult health (Barker et al., 2002). The hypothesis of fetal programming 
implies that changes in the uterine environment as a result of nutritional stress at certain stages of 
conceptus growth and development might permanently change tissue structure and function 
(Drake and Walker, 2004). 
In ruminants, metabolizable protein (MP) is the combination of ruminal undegradable 
intake protein (UIP; protein that escapes rumen microbial breakdown) and bacterial crude protein 
(CP) that enters the small intestine and can be broken down and absorbed by the animal [Figure 
1.1] (Loe et al., 2004). The ewe’s requirement for MP is met from the digestible fractions of the 
microbial CP synthesized in the rumen in proportion to ME intake and the dietary CP that 
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escapes degradation in the rumen (Annison et al., 1959). The requirement for MP to support fetal 
growth in pregnancy is very low in the early stages and only becomes significant in cattle in the 
final 2 mo of gestation or the final month in sheep (Fuller, 2004). This protein requirement takes 
into account the main activities of the body and what is needed to maintain essential functions 
including lactation, pregnancy, and weight change. The amount of MP required for lactation is 
substantial during late pregnancy and has a significant effect on the amount of protein a ruminant 
needs to support pregnancy. Maximal fetal development is important to increase the growth 
potential of animals (Du et al., 2010). Limitations on protein intake inflict a restriction on the 
microbial population in the rumen, which has specific nutrient requirements for optimal growth 
(Robinson, 1982). Maternal nutrition during pregnancy is important in determining optimal fetal 
development, pregnancy outcome, and ultimately lifelong wellbeing of offspring. 
Fetal Development and Nutrition 
Fetal nutrient availability is dependent upon maternal food intake, availability of nutrients 
in the maternal circulation, and the ability of the placenta to efficiently transport substrates to the 
fetal circulation (Battaglia and Meschia, 1988). The placenta forms the interface between 
maternal-fetal circulations and, as such, is critical for fetal nutrition and oxygenation. In turn, the 
placental supply of nutrients to the fetus depends on its size, morphology, blood supply, and 
ability of transport (Belkacemi et al., 2010). An adjustment in the maternal nutrient supply may 
result in altered placental structure and function, consequently hindering fetal nutrition. Wallace 
et al. (1999) investigated the consequences of nutritionally-mediated placental growth restriction 
on ovine fetal organ growth, conformation, and body composition during late gestation. In this 
study, dams were offered a high or moderate level of complete diet to encourage rapid or 
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Liver 
Metabolizable Protein 
Energy MP absorbed 
Excreted 
in urine 
NPN in saliva 
Microorganisms 
 
A 
B Degradable protein 
Excess  
ammonia 
Microbial 
Protein 
Undegradable protein 
Figure 1.1. Metabolizable protein digestion in the rumen. 
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moderate maternal growth rates. After 100 d of gestation, placentome weight was 50% lower in 
high compared with moderate groups and was associated with a 37% reduction in fetal weight (P 
˂ 0.01). All variables of fetal conformation and absolute fetal organ weights, with the exception 
of the adrenal glands, were lower (P ˂ 0.05) in fetuses from high compared with moderate 
groups. Wallace et al. (1999) reported that over-nourishing sheep is associated with not only a 
restriction in placental growth, but also the slowing of fetal growth during the final third of 
pregnancy.  
Maternal undernutrition can also influence placental-fetal development. McCrabb et al. 
(1990) investigated the relationship between placental and fetal weight after placental growth 
was slowed by maternal undernutrition. In this study, single-lamb-bearing ewes were well-fed or 
severely undernourished between the d 30 and d 96 of gestation. They reported an increase (P ˂ 
0.01) in placental weight measured on d 96 (21%) and d 140 (30%) of pregnancy in 
undernourished ewes. Fetal growth, however, was not affected by maternal undernutrition in the 
experiment. In agreement with this study, Faichney and White (1987) found that dietary 
restriction stimulated placental growth in sheep to the extent that fetal growth could be 
maintained when the restriction occurred during the third trimester but not when applied 
throughout the second and third trimesters. 
The placenta reaches maximum cell proliferation between d 50 and 60 of gestation 
followed by culmination of DNA and mass accumulation between d 75 and 80 of gestation 
(Ehrhardt and Bell, 1995). The fetus however, accumulates almost 80% of its eventual mass at 
birth during the final third of pregnancy (Wallace et al., 1997). Maternal nutrition is an important 
determinant of optimal fetal development. However, previous studies call attention to placental 
function as it facilitates the maternal-fetal transfer of nutrients which is critical for development 
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of a healthy fetus. From this information we can see that a combination of factors originating 
from maternal, placental, and fetal nutritional sources act together to regulate the growth of the 
fetus. 
Muscle Growth in Sheep Fetus 
To understand the effects on sheep due to varying levels of maternal MP supplementation 
or restriction during late gestation, it is first necessary to understand the muscle physiology of the 
sheep fetus. Muscle fibers are the structural units of skeletal muscle. The formation of new 
muscle fibers is termed myogenesis, a differentiation process where multipotent stem cells are 
converted into committed muscle cells (Yan et al., 2012). In livestock, all muscle fibers are 
formed during the prenatal stage. Therefore, understanding the prenatal development of skeletal 
muscle is important because events occurring at this stage have dramatic impact on postnatal 
development and growth (Dauncey and Harrison, 1996). 
There are 3 distinct phases of myogenesis during gestation, eventually concluding early 
in the third trimester (Maier et al., 1992; Wilson et al., 1992). Development of primary skeletal 
muscle fibers is initiated during the embryonic stage (Cossu and Borello, 1999). Primary fiber 
formation takes place in the first trimester (d 15 to d 50) and serves as a template for the 
formation of secondary muscle fibers. Mesenchymal stem cells commit to a myogenic lineage 
and form the primary and secondary muscle fibers. Prior to this formation, these cells are 
controlled by a group of regulatory proteins, including Wingless and Int (Wnt), paired box gene 
(Pax) 3 and Pax 7 (Maroto et al., 1997; Hyatt et al., 2008). Wnt signaling is an important factor 
in activating myogenesis, while Pax 3 and Pax 7 induce the expression of myogenic regulatory 
factors (MRF). MRF include myogenin, MRF-4, Myo-D and Myf-5, and their expression leads 
to muscle differentiation. Following formation of primary fibers, the first wave of secondary 
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fiber formation occurs from the end of the first trimester to the middle of the second trimester (d 
48 to d 80). Secondary myotubes form in preparation for the final wave of secondary (tertiary) 
fiber formation. At this time (d 75 to d 105) a second wave of fiber formation allows myotubes 
to fill in the spaces not already occupied by existing fibers, completing myogenesis early in the 
third trimester (Yates et al.,2012). The secondary waves of myogenesis produce the majority of 
muscle fibers. Consequently, the fetal stage during which secondary myogenesis is taking place 
is critical for skeletal muscle development (Greenwood et al., 2000; Du et al., 2010). Moreover, 
since the number of muscle fibers formed during the fetal stage is dependent upon the 
proliferation of myogenic cells, which are highly sensitive to nutrients, maternal nutrition 
dramatically affects skeletal muscle development during this time (Zhu et al., 2004).  
After myogenesis (approximately d 105) is accomplished, muscle growth persists through 
muscle fiber hypertrophy (Greenwood et al., 1999). The size of the muscle fiber depends on 
myoblast and corresponding myonuclei incorporation at this time, resulting in increased DNA 
content (Allen et al., 1979; Trenkle et al., 1978; Davis and Fiorotto, 2009). Nutrition during this 
stage is especially important because sheep are produced primarily for meat. A decrease in the 
number of muscle fibers due to maternal nutrition may permanently reduce muscle mass and 
negatively impact animal performance. The number of fibers in an adult muscle depends on the 
number of primary myotubes first formed, and muscle fiber numbers are sensitive to prenatal 
environmental conditions (Wilson, 1992). 
Proteins within the muscle are divided into several classes based on their cell location and 
solubility. Bate-Smith (1934) revealed differences between intracellular and extracellular 
proteins. Making up 55% of total protein, the myofibrillar protein fraction contains, contractile 
(responsible for muscle contraction), regulatory (control of muscle contraction), and cytoskeletal 
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(support and maintenance of myofibril) proteins that are insoluble in water. There are about 9 
major proteins in this group that are found within a myofibril of an intact muscle (Table 1.2). 
During times of nutritional stress, these proteins are an important source of gluconeogenic 
carbon and essential amino acids (Young, 1970; Waterlow et al., 1978). 
 
Table 1.2. Major myofibrillar proteins in skeletal muscle
1
 
Protein Location % Myofibrillar Protein 
Myosin Thick filaments 43 
Actin Thin filaments 22 
Tropomyosin Thin filaments 5 
Troponin (TnI + TnT = TnC) Thin filaments 5 
Titin Full Sarcomere 8 
Nebulin Thin filaments 3 
Myosin binding protein C Thick filaments 2 
Alpha-actinin Z-lines 2 
M-protein M-lines 2 
Desmin Z-lines ˂ 1 
1
Adapted from Romans, J. R., W. J. Costello, C. W. Carlson, M. L. Greaser, and K. W. Jones. 
2001. The meat we eat. Interstate Publishers, Inc., Danville, IL. p. 900.  
 
Table 1.3. Major sarcoplasmic proteins in skeletal muscle
1
 
Enzyme Content (mg/g) 
Phosphorylase 2.0 
Amylo-1,6-glucosidase 0.1 
Phosphoglucomutase 0.6 
Phosphoglucose isomerase 0.8 
Phosphofructokinase 0.35 
Aldolase 6.5 
Triose phosphate isomerase 2.0 
Glyceraldehyde phosphate dehydrogenase 11.0 
Phosphoglycerate kinase 1.4 
Phosphoglycerate mutase 0.8 
Enolase 2.4 
Pyruvate kinase 3.2 
Lactic dehydrogenase 3.2 
Creatine kinase 5.0 
1
Adapted from Scopes, R. K. 1973. J. Biochem. 134:197. 
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Sarcoplasmic proteins (Table 1.3) account for 30-35% of total muscle proteins and are 
found inside the cell membrane. These proteins are soluble in water and include myoglobin, 
oxidative, glycolytic and lysosomal enzymes (Smyth et al., 1999). Myoglobin is an oxygen-
binding protein found within this group that is responsible for the typical  red color in meat. Both 
myofibrillar are sarcoplasmic proteins have specific roles in development of fetal skeletal muscle 
tissue important in the life of the animal. 
Intrauterine Nutrient Supply and Muscle Development of Offspring 
Maternal nutrition affects fetal development, specifically fetal skeletal muscle 
development (Zhu et al., 2004). The trajectory of skeletal muscle development and growth is 
slowed in fetuses that are nutrient-restricted. Ultrasonic measurements of undernourished fetuses 
show that muscle masses are reduced (Padoan et al. 2004).  
The timing of nutrient restriction is a very important determinant of skeletal muscle 
growth of the fetus. Nutritional insults during early to mid-gestation interfere with myotube 
formation and reduce fiber density in skeletal muscle (Yates et al., 2012). Zhu and others (2004) 
found that maternal nutrient restriction between the middle of first to the middle of the second 
trimester in sheep lowers the number of secondary fibers per fasciculi in the fetal longissimus 
dorsi (LM) muscle. In another study, Quigley (2005) determined that secondary fiber density is 
also lower in the fetal semitendinosus muscle from ewes recovering from malnourishment at 
peri-conception. These data confirm the decrease in fetal myofibers due to maternal nutrient 
restriction during the first trimester. 
Several studies have investigated the effects of maternal under-nutrition in late gestation 
on the development of skeletal muscle in sheep. Estêvão et al. (2011) observed a substantial 
effect on the development of muscle mass in lambs from dams fed a restricted diet (50% of 
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nutrient requirements) when compared with those fed ad libitum during the last six wk of 
gestation. Results from this study indicate that weight at birth and muscle weight are lower in 
lambs from dams fed 50% of nutrient requirements during the last 6 wk of gestation when 
compared to dams fed ad libitum. Everitt and others (1968) found that myofiber number is 
reduced when the dam goes through severe nutritional insult during late gestation. A study 
conducted by Greenwood and others (1999) reported that maternal nutrient restriction during late 
gestation reduces fetal sheep muscle fiber size but not muscle fiber number. Additional research 
is needed in order to study the influence of a more specific nutrient form, such as protein 
supplementation or restriction, on the dam during these critical periods of fetal skeletal muscle 
development.  
Ovine fetal skeletal muscle DNA, ribonucleic acid (RNA), and protein concentrations 
have also been altered by maternal nutrient restriction during late gestation. Quigley et al. (2005) 
found an increase in total muscle fiber number and protein: DNA ratio in fetuses whose mothers 
received a high feed intake over the peri-conception period compared with those whose mothers 
received a low intake, although no change in muscle weight was observed. Others (Greenwood et 
al., 2000) found that DNA, RNA, and protein are significantly reduced in low birth weight lambs 
when compared with that of high weight lambs in a study investigating effects of birth weight on 
growth and development of skeletal muscle in neonatal lambs.  
Despite differences in mass and cellularity, no differences are observed in the frequency 
of Type I or II muscle fibers due to late gestational nutrient restriction (Tygesen and Harrison, 
2005). This is likely because the critical stage for fetal skeletal muscle development, specifically 
fiber formation, is early to mid-gestation in sheep. Alterations in proliferative rate necessary to 
change muscle fiber numbers occurred earlier than the period of nutrient restriction, and the 
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skeletal muscle had most likely reached steady-state by late gestation. Muscle cell proliferation 
has been observed before d 85, and differentiation commences around d 85 (Fahey et al., 2005), 
supporting this hypothesis. Restricted nutrient supply to the fetus also affects postnatal metabolic 
homeostasis in skeletal muscle by reducing glucose oxidation rates, impairing insulin action, and 
lowering the proportion of oxidative fibers (Yates et al., 2012). In animal models of placental 
insufficiency, skeletal muscle fibers have less myonuclei at birth, resulting in fewer myoblasts 
and reduced muscle fiber size. 
Numerous studies have demonstrated that nutrient manipulation during gestation has 
adverse effects on offspring. Lambs grow slower within the first 2 weeks post-partum, 
preventing their ability to properly utilize energy for fat and protein deposition, while having a 
lower intramuscular concentration of DNA, resulting in reduced postnatal skeletal muscle growth 
(Greenwood et al., 1998, 2000). Additionally, a reduced myofiber number in lambs from 
undernourished dams restricts the potential for postnatal compensatory growth of skeletal muscle 
(Wu et al., 2006).  
Together, these data reveal the overwhelming adverse effects of maternal nutrient 
restriction on fetal skeletal muscle growth. From the start of conception, fetal myoblasts can be 
compromised by alterations in maternal nutrition, lowering myonuclei content and altering fiber 
phenotypes, thus preventing normal metabolic regulation. Although common measurements have 
not shown changes in fetal skeletal muscle composition when maternal nutrients are modified 
during late gestation, it does not mean that other aspects of muscle growth are not being affected. 
Proteomics may be applied to take a closer look at the protein profile of muscle, identifying post- 
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translational modifications, protein-protein interactions, and small changes in proteins that may 
provide further insight into the possible effects of maternal nutrition on fetal skeletal muscle 
development during late gestation. 
Proteomics 
Skeletal muscle development of the fetus is influenced by a number of different factors 
such as maternal genetics and environmental factors. During the lifetime of an animal the genes 
remain constant, while the expression of genes to mRNA and proteins is regulated by a large 
number of factors such as environment and developmental conditions which may subsequently 
influence meat quality (Hollung and Veiseth-Kent, 2012). However, understanding the molecular 
mechanisms by which these quality traits are determined requires further investigation. The 
proteome is the complete protein complement expressed by the genome (Wilkins et al., 1996). 
While the genome contains the informationon which genes and alleles are present in the genome, 
the proteome contains information on which genes are actually being expressed and translated 
into proteins. In contrast to the genome, the proteome is constantly changing, influencing protein 
synthesis and degradation. Thus, understanding the variation and different components of the 
proteome with regard to different experimental treatments may lead to knowledge that may be 
used in optimizing growth and development of muscle foods. Proteomics are the means by which 
the proteome is analyzed. With these tools, studies may now be conducted without any prior 
hypothesis on the mechanisms involved. 
The field of proteomics has grown steadily in the last decade due to advances in mass 
spectrometry (MS), genomics, and bioinformatics (Lippolis and Reinhardt, 2008). Essentially, 
there are 2 analytical strategies used in proteomics. One is based on two-dimensional difference 
in-gel electrophoresis (2D DIGE) for separation of proteins, followed by identification of 
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separated proteins by MS. The second is based on liquid chromatography (LC) in one or more 
dimensions coupled with MS. Proteomics experiments can target a certain known protein of 
interest, or an indirect or shotgun approach can be taken. In the shotgun approach large complex 
proteomes are analyzed for changes in protein presence, expression, or modification. The large 
amount of data resulting from this experimental approach can yield unexpected results and may 
depend on the sensitivity of the mass spectrometer and the number of proteins the experiment 
can identify. In contrast to a Western blot, shotgun proteomics requires no specific antibody for 
detection of a protein and can aid in identifying many different proteins simultaneously. 
Mass Spectrometry 
Mass spectrometry measurements are carried out in the gas phase on ionized analytes. 
The mass spectrometer consists of the ion source, mass analyzer (measures the mass-to-charge 
ratio (m/z)), and the detector that registers the number of ions at each m/z value (Mann et 
al.,2001). Tandem MS or LC/MS may also be performed in order to separate peptides on 
reverse-phase high performance liquid chromatography (HPLC). Then the most abundant 
proteins are fragmented by collision-induced-dissociation (CID). This process identifies the 
“daughter ions” by m/z ratio, separating into b and y ions (Ho et al., 2003). The charge remains 
on the amino terminal or on the carboxy terminal fragment with the b and y ions, respectively. 
Matrix-assisted laser desorption/ionization (MALDI) is used in order to identify proteins from a 
gel spot or band collected. The sample is suspended in a matrix of crystals on a plate where 
ultraviolet (UV) lasers excite the analyte ion.  
 By means of MS we can delve further into the global analysis of protein composition, 
post-translational modifications, and the true nature of expression intensities (Aebersold and 
Mann, 2003; Guerrera and Kleiner, 2005; Yates et al., 2009). Mass spectrometry-based 
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proteomics identifies distinct protein species by analyzing trypsin-generated peptide mixtures of 
proteins of interest. Just in the last few years, this technique has successfully catalogued several 
hundred of the most abundant and soluble muscle-associated protein species and identified 
several thousand distinct protein isoforms present in skeletal muscle tissues (Capitanio et al., 
2005; Hojlund et al., 2008; Raddatz et al., 2008; Parker et al., 2009). 
Technical advances have improved the sensitivity and accuracy of mass spectrometers 
necessary for proteomic work (Lippolis and Reinhardt, 2008). Despite these improvements, a 
number of issues cause difficulty during protein identification. For example, the number of 
proteins that comprise the human proteome is approximately 30,000 proteins, not counting 
alternative splicing and post-translational modifications (Cho, 2007). Also, the range of protein 
expression interferes with detection of low abundance proteins in typical biological samples 
(Lippolis and Reinhardt, 2008). One of the most common examples of this obstacle is that of 
plasma. Nearly half of the protein in plasma is albumin, and the top 10 proteins in plasma make 
up nearly 90% of the total protein (Cho, 2007). As a result of these challenges, many protein 
separation methods before MS have been developed in order to create less complex mixtures for 
a more complete identification of proteins. Fractionation can be achieved by subcellular 
fractionation, enrichment strategies, chromatography, or gel electrophoresis (Stasyk and Huber, 
2004). The goal of all protein or peptide separation methods is to better enable detection of all 
the proteins in a proteome. Mass spectrometry-based proteomics are useful when confirming a 
particular protein or protein modification. The method can also be used as a screening tool for 
protein-protein and protein-DNA interactions. However, MS proteomics should not be used as a 
stand-alone method for biological/physiological studies. Mass spectrometry can be biased toward 
the more predominant peptides, which may result in an incorrect identification. 
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Fluorescence Two-Dimensional Difference In-Gel Electrophoresis 
The fluorescent 2D DIGE method involves direct labeling of the lysine groups on 
proteins with cyanine (Cy) dyes before isoelectric focusing. This advancement in 2D DIGE 
technology generates the ability to label 2 to 3 samples with different dyes and electrophorese all 
the samples on the same 2D gel, thus reducing spot variability and the number of gels in an 
experiment, while yielding simple and accurate spot matching (Tannu and Hemby, 2006). The 
cyanine dye (CyDye) DIGE fluor minimal dye had an N-hydroxysuccinimidyl ester reactive 
group. CyDye is designed to form a covalent bond with the epsilon amino group of lysine in 
proteins via an amide linkage. The single positive charge of the CyDye replaces the single 
positive charge of the lysine at neutral and acidic pH, keeping the isoelectric point (pI) of the 
protein relatively unchanged. The labeling reaction is dye limiting and the ratio of CyDye to 
sample (100 to 300 pmol: 50 µg) ensures that the dyes label approximately 1 to 2% of lysine 
residues. Therefore, each labeled protein carries only one dye label and is visualized as a single 
protein spot.  
The most common experimental design for a 2D DIGE experiment is one in which a 
pooled internal standard is labeled with cyanide cyanine 2 yellow dye (Cy2) dye and the 
treatment and/or control groups are labeled with either cyanine 3 red dye (Cy3) or cyanine 5 blue 
dye (Cy5) dyes. The internal standard acts to decrease biological and experimental between-gel 
variation and improves statistical analysis. Utilizing this design, the individual protein data from 
control and/or treatment samples are normalized against the Cy2-labeled sample. 
Utilizing the above experimental design for 2D DIGE, Anderson et al. (2012) reported 
the release of myosin light chain 1 (MLC1) from the myofibrillar fraction of postmortem aged 
bovine LM muscle as a potential indicator of proteolysis and tenderness in beef. Labeling d 1 
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postmortem with Cy3, d 14 postmortem with Cy5, authors were able to measure intensities of 
both the sarcoplasmic and Myofibrillar protein fractions. In this study, 12 spots the differed in 
relative abundance (P < 0.10) between the two treatment groups (high star probe vs. low star 
probe value steaks) were identified. 
Although the use of this technology in the field animal science is relatively new, it holds 
great potential as a method for furthering our understanding of complex biological systems that 
control the physiology and pathology of our livestock species. The use of 2D DIGE has been 
used in meat science to identify the protein profile of muscle, including postmortem changes that 
alter the structure of the myofibril to identify potential indicators of tenderness (Hollung et al., 
2007). Hamelin et al. (2006) observed post-translational modifications and protein fragments in 
his proteomic analysis of ovine muscle hypertrophy. Key proteins associated with energetic 
metabolism, contractile apparatus, detoxification, and regulators were identified and 
investigated. In their study, the same protein was found in different spots at different pI and 
molecular weight locations within a muscle, between different muscles, or both. These different 
locations are thought to correspond to different isoforms that can result from the expression of 
different genes. Also, these isoforms may be triggered by post-translational modifications such 
as oxidation, glycosylation, phosphorylation, and proteolytic cleavage. Upon analyzing the 
semimembranosus (SM) vastus medialis (VM), LM, and fasciae latae from Romanov ewes and 
Belgian Texel rams, it was observed that isoforms differentially expressed between genotypes 
showed similar patterns of between-muscle expressions. This study demonstrated the capability 
proteomics holds to discover how the functional abilities of muscle may require different protein 
isoforms, leading to a greater understanding of the energetic metabolism of muscle. In another 
study concerning hypertrophy, Bouley et al. (2004) utilized 2D DIGE followed by MS in order 
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to identify the key proteins that determine bovine meat quality. This method resulted in the 
identification of 75 proteins, including several troponin-T (TnT) isoforms, helping us to better 
understand the physiology of our muscle foods. 
There have been few published studies to date investigating offspring organ and muscle 
development as affected by maternal nutrition using the proteomic approach. Sarr et al. (2010) 
observed numerous differences in abundance of the adipose tissue proteome of neonatal piglets 
from high protein and low protein supplemented German Landrace sows when compared with 
the control. Several of these differences included enzymes that participate in successive steps of 
glycolysis, a metabolic pathway that contributes to lipid accumulation in adipose cells (Temple 
et al., 2007). The protein transaldolase-1 was found to be greater in low protein piglets than 
control piglets, providing a link between the glycolytic pathway and the pentose phosphate 
pathway to produce reduced NADPH for lipogenesis (Wamelink et al., 2008). With the use of 
proteomics, it was possible to determine glucose conversion into fatty acids as an early 
upregulated route in response to the prenatal low protein diet. Once integral muscle proteins are 
sequenced via proteomics, correlation of these findings with genomic, transcriptomic, and 
metabolic databanks in order to establish the overall relationship in striated voluntary muscle 
tissues will increase understanding of fetal skeletal muscle development (Yi et al., 2008). 
Investigation of the fetal skeletal muscle proteome as influenced by maternal protein 
supplementation may lead to a better understanding of the molecular mechanisms behind fetal 
growth efficiency. 
Maternal nutrition during late gestation is crucial to the successful development and 
growth of the fetus. Further research is necessary to better understand the role of supplementing 
protein in an isocaloric diet to further realize the effects of maternal nutrition on fetal organ 
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growth and skeletal muscle development. A better understanding of the effects of maternal MP 
supplementation in an isocaloric diet on the effects of gestational nutrition on fetal growth 
efficiency will allow for the development of management strategies to optimize livestock 
performance. 
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CHAPTER 2. INFLUENCE OF METABOLIZABLE PROTEIN SUPPLEMENTATION 
IN LATE PREGNANCY ON VISCERAL ORGAN MASS AND INDICES OF MUSCLE 
GROWTH IN SHEEP 
Abstract 
The objective of this study was to evaluate the effects of maternal metabolizable protein 
(MP) supply during late gestation on fetal growth and organ development in sheep. Multiparous 
singleton pregnant ewes (n = 18) were randomized to receive 1 of 3 diets that were isocaloric and 
formulated to supply 60% (MP60), 100% (MP100), or 140% (MP140) of MP requirements 
during late gestation (d 100 to 130). Metabolizable protein requirements were calculated as: MP 
(g/d) = (CP, g/d × (64 + (0.16 × undegraded intake protein of diet)))/100. Pregnant ewes and 
fetuses were euthanized and necropsied on d 130 ± 1 SD of gestation. Data were analyzed using 
PROC GLM of SAS. There was no effect (P ≥ 0.12) of maternal MP supplementation during late 
gestation on fetal BW, empty BW, curved crown rump length, heart girth circumference, or 
adrenal, brain, heart, kidney, lung, pancreas, large intestine, spleen, and stomach weights when 
expressed as g or as g/g BW. Fetuses from MP140 ewes had increased (P ≤ 0.05) small intestinal 
mass (8.8 ± 0.4 g/g BW) at d 130 compared with fetuses from MP60 (7.3 ± 0.5 g/g BW) and 
MP100 (7.0 ± 0.5 g/g BW) ewes. Fetuses from MP60 ewes had increased (P ≤ 0.05) perirenal fat 
mass (21.4 ± 1.59 g/g BW) compared with fetuses from MP100 (15.5 ± 1.5 g/g BW) and MP140 
(17.2 ± 1.5 g/g BW) ewes. Although all pregnant ewes were provided adequate energy, 
restricting levels of MP supply during the defined period of gestation increased fetal perirenal fat 
whereas high levels of MP supply increased fetal small intestinal mass, all while not altering 
fetal BW. 
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Introduction 
Nutrition of the ewe during late gestation directly relates to the growth of the fetus (Binns 
et al., 2002). Fifty percent of fetal growth takes place during the final 4 wk of pregnancy in 
addition to major redistribution of the ewe’s body reserves to support udder development and 
colostrum production (Robinson, 1983). Supplementation with protein sources is necessary to 
meet nutrient supply as failure to increase feed intake can lead to reduced lamb birth weight 
(Annett et al., 2005).  
Although several studies report negative (Ocak et al., 2005) or no effects (McNeil et al., 
1997; Dawson et al., 1999) of MP supplementation during late gestation on the performance of 
pregnant ewes and particularly negative effects on colostrum yield and post-natal lamb survival, 
there is limited information regarding the effect of MP supplementation during late gestation on 
fetal visceral organ development. In a study offering isoenergetic diets providing 41 Afshari 
ewes metabolizable protein at 100%, 114%, or 124% of requirements, Amanlou et al. (2011) 
observed no effect of maternal protein supplementation during the last 3 wk of gestation on lamb 
birth weight or BW at weaning. Schauer et al. (2010) offered protein supplements in the last third 
of gestation providing 0.11% of BW/d of CP until lambing based on intake and protein 
requirements (NRC, 1985). In agreement with the previous study, Schauer et al. (2010) reported 
no effect of protein supplementation during late gestation on lamb birth weight. 
The maternal gastrointestinal tract responds to both stage of pregnancy and nutritional 
level during gestation (Scheaffer et al., 2004; Reed et al., 2007), indicating that the dam may 
compensate for inadequate nutrition, sparing her offspring. Protein supplementation during the 
last third of pregnancy is crucial to support fetal growth and the increasing demands of the ewe 
to support mammary tissue development. Metabolizable protein requirements of sheep increase 
 29 
 
with advancing gestation, with the greatest demand in late pregnancy. The last third of pregnancy 
is also an ideal time to nutritionally manage dams as they are commonly brought in from pasture 
just prior to lambing. If dams are not provided adequate protein during late gestation, lambs will 
likely experience slower growth and average daily gain (ADG). This study tested the hypothesis 
that altering levels of maternal MP in isocaloric diets during late gestation impacts fetal growth 
and organ development. 
Materials and Methods 
This study was conducted at the North Dakota State University Animal Nutrition and 
Physiology Center (ANPC). All animal care and handling procedures were approved by the 
Institutional Animal Care and Use Committee. 
Experimental Design 
Rambouillet ewes were transported to the ANPC (Fargo, ND) in July of 2011 from 
Hettinger, North Dakota. Upon arrival ewes were synchronized for estrus using progesterone 
inserts (CIDR, Pfizer Animal Health, New York, NY) for 7 d. Initially, 52 ewes were divided 
evenly into 4 separate pens with ad libitum access to hay and water. Ewes were mated with rams 
of proven fertility equipped with mating harnesses and marking crayons to obtain mating dates. 
Mating was recorded every 12 h. Pregnancy was confirmed and embryos were enumerated at 32 
± 4 d post-breeding via trans rectal ultrasonography (Aloka SSD-3500; Aloka America, 
Wallingford, CT) with a 7.5 MHz, linear trans-rectal probe, as described by Schrick and Inskeep 
(1993). Ewes carrying multiple conceptuses were administered 20 mg intramuscularly (IM) of 
Lutalyse (Pfizer Animal Health, New York, NY) and reintroduced to the rams 2 wk later. On d 
90 of gestation dams carrying singleton pregnancies (n = 18) were housed in individual pens 
(0.91 x 1.2 m) at ANPC for the remainder of the experiment. All dams were acclimated to a 
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common diet (Table 2.1) and ad libitum access to water. Diets were analyzed for DM, ash, and 
CP following AOAC (1990), and NDF and ADF using an Ankom Fiber Analyzer (Ankom 
Technology, Fairport, NY). 
Table 2.1. Ingredient composition and analyzed nutrient composition of diets fed to ewes from 
d 100 to d 130 of gestation 
 Treatment
1
 
Item MP60 MP100 MP140 
Ingredient, % of dietary DM    
Supplement    
Corn 30.00 19.00 - 
DDG
2
 4.00 24.00 43.00 
Soyhulls 9.00 - - 
Trace mineral
3
 0.49 0.49 0.49 
    
Fescue straw 56.51 56.51 56.51 
    
Analyzed dietary composition, % DM    
DM 89.24 89.92 90.78 
CP 6.57 10.25 14.60 
NDF 58.60 59.36 65.42 
ADF 34.28 32.02 34.05 
Ash 6.42 6.54 7.11 
1
Maternal diets (DM basis) were balanced for mature ewes baring singletons during the last 4 
weeks of gestation according to NRC (2007). Treatments: MP60 = 60% of MP requirements, 
MP100 = 100% of MP requirements, MP140 = 140% of MP requirements. 
2
Dried distillers grains with solubles. 
3
Trace mineral content: 16.0 to 17.0% Ca; 8.0% P; 21.0 to 23.0% salt; 2.75% Mg; 3 ppm Co; 5 
ppm Cu; 100 ppm I; 1,400 ppm Mn; 20 ppm Se; 3,000 ppm Zn; 113,500 IU/kg vitamin A; 
11,350 IU/kg vitamin D; and 227 IU/kg vitamin E.
 
 
Metabolizable protein treatments began on d 100 of gestation. Dams were supplemented 
with 140% of the MP requirement (MP140), 100% of the MP requirement (MP100), or 60% of 
the MP requirement (MP60) based on NRC (2007) requirements. Diets were isocaloric and 
balanced to meet the energy requirements of 70-kg mature ewes bearing singletons (NRC, 2007). 
Metabolizable protein requirements were based on the CP requirements of a ewe consuming a 
40% RUP ration (NRC, 2007). Metabolizable protein supplied was calculated as: MP (g/d) = 
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(CP, g/d × (64 + (0.16 × undegradable intake protein (UIP) of ration))))/100. To account for 
variability in nutrient concentration of dried distiller grain (DDG) and other diet constituents, 
feedstuffs were analyzed for nutrient density just prior to the start of the treatment period. Ewes 
were blocked by BW into 1 of 3 treatments, housed individually, and weighed every 7 d to adjust 
the rations of MP supplement and corresponding hay for changes in BW throughout the 
experiment. All ewes were individually offered their respective MP supplement, and there were 
no refusals. The hay portion of the diet was given to the ewes shortly after the MP supplement 
had been consumed. Orts were collected once every 7 d, and there were rarely refusals 
throughout the treatment period. 
Maternal BW was determined on a weekly basis. Maternal body condition was scored (1 
to 5 scale, with 1 = emanciated and 5 = obese) by 2 separate evaluators on d 90, 110, and 130 of 
gestation (± 2.0 d; SE). Ultrasound measurements for ewe back fat thickness and LM area at the 
12
th
 rib were determined using an Aloka 500-SSV (Aloka America, Wallingford, CT) with a 
linear transducer probe on d 90, 110, and 130 of gestation (± 2.0 d; SE). Maternal jugular vein 
blood samples were collected 1 h prior to feeding on d 100, 110, 120, and 130 of gestation (± 0.8 
d; SE). Serum was separated by centrifugation and stored at -20˚C until determination of blood 
urea N (BUN) concentration for d 100 and d 130. 
Tissue Collection and Analyses 
 On d 130 of gestation dams were not fed. All dams were weighed just prior to being 
stunned by captive bolt and exsanguinated. Final ewe BW was reported as the average BW 
measured on d 129 and d 130 of gestation just prior to exsanguination. The blood was 
quantitatively collected and weighed. The gravid uterus was immediately collected, and the fetus 
was removed and weighed. Fetal membranes were removed, and placentomes were dissected 
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from the uterine wall and counted. Placental caruncular and cotyledonary tissues were separated 
and weighed. The umbilical artery was located, and blood samples were collected into tubes, 
allowed to clot on wet ice, and later centrifuged at 2,000 x g for 20 min at 4˚C. Serum was stored 
at -20°C until further analysis. Both maternal and fetal viscera were removed, and the liver, 
mammary, and pancreas were dissected from the viscera and weighed. Fetal curved crown rump 
(CCR) length and abdominal girth were recorded. Fetal ponderal index was calculated using the 
following equation: ponderal index = fetal weight (kg) / CCR length (m
3
). Fetal organ weights 
were recorded. Attached adipose tissue and digestive contents were removed from the 
gastrointestinal tract, and weights of liver, kidneys, stomach, small intestine, and lower 
gastrointestinal tract were recorded. In addition to weight, fetal hearts were further processed; the 
average left and right ventricle thicknesses were assessed with digital calipers at the base, mid, 
and top portions of the ventricle. Lastly, prominent portions of right and left sides of the LM, 
semimembranosus (SM), and psoas major (PM) were dissected from each lamb to provide 
adequate sample for tissue analysis. The samples were immediately frozen in liquid nitrogen and 
stored at -80˚C until further analysis. 
Tissue Cellularity Estimates 
Frozen muscle tissue samples (5 g) were homogenized using a Polytron with PT-10s 
probe (Brinkmann, Westbury, NY) in 1 × TNE (10 mM Tris, 0.2 mM NaCl, 1 mM 
ethylenediamine tetraacetic acid (EDTA), pH 7.4), and RNA and DNA were extracted by the 
method of Schmidt-Thannhause (1945) as described in Munro and Fleck (1966). DNA was 
determined using diphenylamine reagent (Burton, 1956). RNA was determined using orcinol 
reagent prepared as described by Lawson et al., (1988). Protein concentration in the homogenate 
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was determined using BioRad Quick Start Bradford Protein Reagent (BioRad, Hercules, CA; 
Bradford et al., 1976) after solubilizing in 0.1 M NaOH. 
Statistical Analysis 
Fetal visceral organ data were analyzed using the PROC GLM procedure of SAS (SAS 
Inst. Inc., Cary, NC) with MP treatment (MP60 vs. MP100 vs. MP140) and fetal weight in the 
model. Ewe organ weights, uterine weight, and placental measurements were analyzed using 
PROC GLM with MP treatment in the model. Measurements taken over time were analyzed 
using PROC MIXED procedures of SAS with MP treatment, time during MP treatment, and time 
by treatment as the source of variation in the model. Means were separated using the LSMEANS 
option of SAS and were considered significant when P ≤ 0.05. 
Results and Discussion 
Maternal Measurements at d 130 of Gestation 
Ewe BW was not affected (P = 0.84) by MP supplementation or restriction during late 
gestation (Figure 2.1; Table 2.2). There was an effect of MP treatment observed in maternal BW 
change (Figure 2.2), with ewes receiving the MP100 treatment gaining more weight throughout 
the treatment period than ewes receiving the MP60 treatment, with MP100 being intermediate. 
Ocak et al. (2005) reported that feeding of pregnant ewes 140% of the CP requirements during 
the last 6 wk of pregnancy increased ewe live weight at lambing, which is in contrast with our 
observations in the present study. The CP diet offered was not formulated to be isocaloric. Ewes 
were offered additional calories when compared to the control, which provided 100% of CP 
requirements in the study conducted by Ocak et al. (2005). Supplementation of CP in the 
maternal diet may have increased maternal body protein, while the supplementation of MP in 
isocaloric diets in the present study did not significantly affect the dam’s body condition. 
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Figure 2.1. Average BW of ewes fed diets formulated to supply 60% (MP60), 100% (MP100), 
or 140% (MP140) of MP requirements (NRC, 2007) during late (d 100 to d 130) gestation. 
 
 
Figure 2.2. Average BW change of ewes fed diets formulated to supply 60% (MP60), 100% 
(MP100), or 140% (MP140) of MP requirements (NRC, 2007) during late (d 100 to d 130) 
gestation. 
 
Parallel to BW, ewe BCS was not affected by treatment throughout gestation. Ewes had 
healthy body condition at the start of the experiment and therefore less likely to use dietary 
protein to replenish their own body reserves. The current study also used multiparous ewes, 
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which may have had a lower requirement for maintenance compared with that of a growing, 
primiparous ewe. There was no impact of MP treatment on ewe LEA or BF ultrasound 
measurements taken on d 100 and d 130 of gestation. However, there was an influence of MP on 
BF, with ewes receiving the MP140 treatment having less BF on d 130 of gestation when 
compared to the start of treatment. Ewe liver, mammary, and pancreas weights were not affected 
(P ≥ 0.17) by MP treatments during late pregnancy (Table 2.2). Previous studies by others 
(Scheaffer et al., 2004; Reed et al., 2007; Carlson et al., 2009; Caton et al., 2009) found visceral 
organ weights are unresponsive to changes in nutrient intake during gestation. From these data 
we can conclude that even when calories are reduced, there is no change in fetal organ masses. 
Metabolizable protein supplementation or restriction during late gestation did not affect 
ewe gravid or empty uterine weight (P ≥ 0.94) or placentome weight and associated caruncle and 
cotyledon weights (Table 2.2). Placentome number in sheep is established by d 40 of gestation 
and remains constant thereafter (Schneider, 1996; Heasman et al., 1999). A previous study 
(Vonnahme et al., 2006) investigated the capability of ewes to protect their own fetus from a 
bout of maternal undernutrition by converting placentomes to more efficient forms. Different 
placental responses may function to maintain normal nutrient delivery to the developing fetus 
during periods of nutritional insult. In the present study, ewes were not treated until d 100 of 
gestation, well after placentome number is established. Therefore, as was expected from previous 
research, placentome number was unaffected (P = 0.73) by protein alteration, even when 
restricting ewes to 60 % of MP requirements during the last third of pregnancy. 
Blood Metabolites 
Blood urea nitrogen (BUN) concentration has been suggested to be a realistic predictor of 
nutrient utilization (Nolan et al., 1970; Egan and Kellaway, 1971) of sheep. In the present 
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Table 2.2. Ewe BW, organ weights, carcass and placental measurements on d 130 of gestation 
as influenced by MP supplementation during late (d 100 to d 130) gestation 
 Treatment
1
   
Item 
MP60 
n = 6 
MP100 
n = 6 
MP140 
n = 6 SE P - value 
Initial body weight, kg 60.39 60.32 60.08   
Body weight, kg 63.56 67.77 66.21 4.29 0.84 
Liver, g 558.17 631.93 688.57 46.09 0.17 
Mammary, g 595.33 518.52 478.02 102.19 0.72 
Pancreas, g 61.78 67.82 67.60 6.22 0.74 
Back fat, cm 0.28 0.32 0.33 0.02 0.31 
Loin eye area, cm
2
 8.66 10.08 9.31 0.63 0.57 
Gravid uterus weight, g 6411.60 6366.65 6436.03 302.22 0.98 
Empty uterus weight, g 625.80 617.63 639.58 43.83 0.94 
Total placentome weight, g 390.42 431.47 367.15 28.86 0.31 
Placentome number 69.83 77.00 73.83 6.29 0.73 
Caruncle weight, g 92.75 106.83 101.73 10.91 0.67 
Cotyledon weight, g 279.02 317.17 248.47 20.48 0.09 
1
Treatments: MP60 = 60% of MP requirements, MP100 = 100% of MP requirements, MP140 
= 140% of MP requirements (NRC, 2007). 
 
study, BUN concentration reflected ewe MP treatment during late gestation (Figure 2.3). No 
differences among treatments were detected for BUN concentrations on d 100 (P ˃ 0.17) of 
gestation prior to initiation of treatment. As expected, differences in BUN resulting from dietary 
MP levels were observed on d 130 of gestation; MP140 ewes had higher (P ˂ 0.001) BUN 
concentration on d 130 of gestation when compared to the start of treatment. MP60 ewes had a 
lower (P ˂ 0.001) BUN concentration on d 130 of gestation when compared to the start of 
treatment. Ewes receiving the MP100 treatment maintained a consistent BUN concentration 
throughout the treatment period.  
The use of BUN levels in ruminants has has been used to assess the value of feed protein 
on the basis that BUN levels appear to reflect ammonia production in the rumen (Lewis, 1957). 
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Figure 2.3. Blood urea nitrogen levels of ewes fed diets formulated to supply 60% (MP60), 
100% (MP100), or 140% (MP140) of MP requirements (NRC, 2007) during late (d 100 to d 130) 
gestation. 
 
Increased concentrations of BUN in ewes fed a higher supply of MP suggest greater nitrogen 
excretion. Sunny et al. (2007) suggests that although urea nitrogen in sheep is highly dependent 
on plasma urea concentration, it is also dependent on the efficiency of capture within the 
digestive tract. Salvage is greatly influenced by microbial fermentation events occurring within 
the gastrointestinal tract (GIT) and further investigation of the relationship between plasma urea 
concentration and urea nitrogen recycled to the GIT is needed. 
Fetal Measurements at d 130 of Gestation 
Fetal BW or eviscerated body weight (EBW) were not affected (P ≥ 0.67) by maternal 
MP supplementation during late gestation (Table 2.3). The amino acid transfer from maternal 
circulation to fetal tissue is adjusted during its course, and McNeil et al. (1997) reported the low 
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ability of the placenta to transfer excess amino acids to the fetus. In contrast to this observation, 
Ocak et al. (2005) found that high protein diet pre-partum increased lamb birth weight. Carlson 
et al. (2009) reported that fetal weight (FW) is similar in lambs from ewes that were nutrient 
restricted or maintenance-fed throughout late gestation; however, others (Trahair et al., 1997; 
Vonnahme et al., 2003; Luther et al., 2007) have found that fetal weight is reduced when ewes 
are restricted in early to mid-gestation (d 78 to d 90), while Swanson et al. (2008) demonstrated 
that maternal nutrient restriction during the last two thirds of pregnancy in sheep reduces birth 
weights. In the case of nutrient excess, Wallace et al. (1996, 1999, 2001) found that over 
nourishing the singleton-bearing ewe throughout gestation results in rapid maternal growth at the 
expense of the nutrient requirements of the gravid uterus, resulting in low-birth weight lambs.  
These findings substantiate the adverse effects forced upon the growing fetus caused by 
the alteration of maternal nutrient supply at critical windows of development. However, it is 
important to note that the above studies did not use diets formulated to be isocaloric. The lack of 
similar response in the current study is most likely attributable to the offering of MP in isocaloric 
diets. These data may also differ due to the level of MP supplementation or the timing, length, 
and (or) type of restriction. Fetal growth is the greatest over the final third of gestation and 
changes in the maternal diet during this period can have the greatest effect on birth weight in 
sheep. Nutrient restriction during late gestation can also lead to adverse effects on offspring’s’ 
postnatal metabolism and performance. Tygesen et al. (2007) found that a 50% reduction of 
maternal nutrient supply in the last six weeks of gestation reduces the birth weight and pre-
weaning growth of the offspring due to lower milk intake, The differences that Tygesen et al. 
(2007) observed in the growth pattern of restricted lambs vs. control lambs suggests that prenatal 
undernutrition during late gestation may program postnatal metabolism.  
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Fetal CCR and abdominal girth were not different (P ≥ 0.50) between groups. Maternal 
MP treatment had no effect on fetal brain, lung, adrenals, heart, and kidney, liver, spleen, and 
pancreas weights (P ≥ 0.40; Table 2.3) when expressed alone or per unit of FW. Fetal heart 
weight, heart weight relative to FW, and left and right ventricular thicknesses were not different 
(P ≥ 0.43) between treatment groups (Table 2.3). Fetal total perirenal fat mass (Table 2.3), when 
expressed per unit of FW, was greater (P = 0.03) in fetuses from MP60 dams compared with all 
other treatments. 
Perirenal adipose tissue has marked proliferation of mitochondria between d 80 and 90 of 
gestation, with the tissue developing into brown fat and cell profiles characterized by many 
mitochondria with numerous distinct cristae (Gemmel and Alexander, 1978). Several studies 
(Alexander 1978; Budge et al., 2000; Symonds et al., 1998) found maternal nutrition to influence 
lipid reserves and brown adipose tissue deposition in newborn lambs. Interestingly, increased 
nutrition does not necessarily result in increased adipose tissue deposition. Budge et al. (2000) 
investigated the effects of maternal overfeeding during pregnancy (150% vs. 100% in controls) 
and reported fetuses from well-fed ewes have less total perirenal brown adipose tissue than 
control fed fetuses. In contrast, Alexander et al. (1978) found that pregnant ewes fed a restricted 
diet from 12 wk gestation onwards causes a decrease in brown adipose tissue deposition (g per 
kg body weight) of the offspring. Our results from the present study, along with the results 
above, suggest there is an optimal energy requirement of brown adipose tissue in the growing 
fetus, regardless of how much of the diet is composed of protein. Due to the fact that most fat in 
newborn lambs is internal, brown adipose tissue from well-fed fetuses has an increased 
thermogenic potential when compared with those mothers control-fed throughout pregnancy 
(Budge et al., 2000).  
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Table 2.3. Ovine fetal organ development on d 130 of gestation as influenced by level of 
maternal MP supplementation during late (d 100 to d 130) gestation 
 Treatment
1
   
Item 
MP60 
(n = 6) 
MP100 
(n = 6) 
MP140 
(n = 6) SE P-value 
Fetal weight, g 3461 3611 3424 156 0.67 
Fetal eviscerated weight, g 2598 2723 2630 114 0.73 
CCR
2
 length, cm 50.8 51.3 50.4 1.4 0.91 
Abdominal girth, cm 35.0 33.0 35.1 1.4 0.50 
Brain, g 49.46 50.66 51.76 1.98 0.72 
Lung, g 112.42 113.68 115.78 5.95 0.92 
    Lung/FW
3
, g/kg 33 31 34 1.56 0.49 
Adrenal, g 0.32 0.35 0.33 0.02 0.67 
    Adrenal/FW, g/kg 92 97 95 7 0.87 
Heart, g 25.81 26.25 25.87 1.62 0.98 
    Heart/FW, g/kg 7.47 7.23 7.53 0.24 0.68 
Left ventricle thickness, mm 5.97 5.57 6.14 0.31 0.43 
Right ventricle thickness, mm 4.31 4.52 4.29 0.25 0.43 
Kidney, g 20.41 19.58 20.08 1.01 0.85 
    Kidney/FW, g/kg 6.1 5.4 5.9 4.45 0.58 
Perirenal fat, g 21.38 15.58 17.28 1.60 0.06 
    Perirenal fat/FW, g/kg 6.2
a
 4.4
b
 5.0
b
 0.44 0.03 
Liver, g 95.15 93.00 92.61 6.36 0.95 
    Liver/FW, g/kg 27.6 25.7 26.9 1.27 0.56 
Spleen, g 5.41 5.71 5.89 0.32 0.58 
    Spleen/FW, g/kg 1.57 1.58 1.72 0.08 0.40 
Pancreas, g 3.08 3.13 3.19 0.26 0.95 
    Pancreas/FW, g/kg 0.88 0.86 0.93 0.05 0.74 
Stomach complex
4
, g 25.13 25.02 23.48 2.26 0.85 
    Stomach complex/FW, g/kg 7.29 6.91 6.96 0.61 0.89 
Small intestine, g 25.39 25.54 29.88 2.08 0.22 
    Small intestine/FW, g/kg 7.37
b
 7.06
b
 8.79
a
 0.45 0.05 
Large intestine, g 9.39 8.53 9.20 0.61 0.59 
    Large intestine/FW, g/kg 2.7 2.4 2.7 1.3 0.17 
1
Treatments: MP60 = 60% of MP requirements, MP100 = 100% of MP requirements, MP140 
= 140% of MP requirements (NRC, 2007). 
2
CCR = curved crown rump.
 
3
FW = fetal weight.
 
4
Stomach complex = (reticulum + rumen + omasum + abomasum) – digesta. 
a,b
Values within rows with different superscripts are significantly different ( P ≤ 0.05). 
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Thus, a sufficient amount of adipose tissue at birth would better facilitate thermoregulation, and 
the lamb would be less susceptible to death from hypothermia.  
Although fetal small intestinal mass did not differ (P = 0.22) between groups when 
expressed alone, fetuses from MP140 dams had increased (P = 0.05) small intestinal mass (Table 
2.3) when expressed per unit of FW compared with all other treatments. Fetal large intestinal 
mass was unaffected (P = 0.17) by altering levels of maternal MP during late gestation. The 
effect of maternal protein supplementation during specific stages on gestation on the small 
intestine has not been extensively studied. The alterations in fetal small intestinal mass may be 
explained by changes in cellularity, cell proliferation, and vascularity in response to both 
maternal diet and fetal nutrient demand with advancing gestation. Increased small intestinal 
weights are important when considering postnatal growth of the lamb. Successful adaptation to 
the extrauterine environment is dependent on the ability of the neonate to obtain nutrients from 
ingested milk rather than from the placenta (Avila et al., 1989). Thriving gastrointestinal 
development during fetal life is dependent upon proper nutrition during gestation. 
Visceral organ mass response to a differing amount of maternal MP during late gestation, 
such as in this study, and during early to mid-gestation are likely dependent upon the different 
developmental periods of the fetus and its organ systems (Fowden et al., 2006; Nathanielsz, 
2006; Symonds et al., 2007). Normally, organogenesis occurs during early to mid-gestation, 
followed by rapid fetal growth in the last third of gestation (Fowden et al., 2006). However, each 
organ and tissue grows and develops at a unique rate. Various organ systems may respond 
differently to specific timing and severity of nutrient supplementation or restriction because of 
differing growth trajectories and maturation time points (Caton and Hess, 2010). In the present  
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study growth may have occurred due to increased efficiency of nutrient usage by the dam and/or 
the fetus following MP restriction, thus, fetal organ growth and development was minimally 
affected. 
Tissue Cellularity 
Regardless of muscle type, fetal skeletal muscle protein content, protein:DNA and 
RNA:DNA ratios were not affected (P ≥ 0.26) by maternal MP treatment (Table 2.4). Previous 
studies have suggested that, in sheep, myogenesis is completed between d 80 and 125 of 
gestation (Ashmore et al., 1972; Swatland and Cassens, 1973; Maier et al., 1992). It appears that 
altering maternal MP during the treatment interval of our study (d 100 to d 130) did not alter 
fetal skeletal muscle hypertrophy. Fetal LM total DNA content tended to be greater in those from 
MP100 ewes compared with those from MP60 and MP140 ewes (P = 0.09). Fetal LM DNA 
content was not sensitive to maternal nutrition when ewes were offered either high or low levels 
of MP; however an adequate amount of maternal protein may have had a positive effect on fetal 
LM hyperplasia (Swanson et al., 1999; Scheaffer et al., 2004; Soto-Navarro et al., 2004). Fetal 
SM total RNA content from MP140 ewes tended (P = 0.06) to be greater compared with that of 
MP60 and MP100 treated ewes (Table 2.4). RNA content is dependent upon the muscle location 
and the fraction of slow and fast muscle fibers. It has been established that isometric contractile 
characteristics of fast and slow-twitch muscle is determined in fetal sheep between d 90 and 140 
of gestation (Javen et al., 1996). Increased fetal muscle RNA from MP140-supplemented ewes 
could be explained by developmental changes in muscle gene expression due to the significant 
increase in maternal MP during such a critical period of fetal growth. In agreement with past 
research (Fahey et al., 2005; Daniel, et al., 2007), the three fetal muscles evaluated in the present 
study were not affected equally by maternal nutrition. During late gestation, nutrients received 
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by the fetus are distributed in order of physiological importance to the corresponding organ 
systems: brain, liver, heart, etc. Our results on indices of fetal muscle growth infer that fetal 
muscle development is sensitive to periods of fetal nutrient manipulation. Reducing or 
supplementing maternal protein during late pregnancy had little effect on fetal muscle cellularity, 
although differences in DNA and RNA content demand further investigation into fiber type and 
impacts on subsequent mature muscle. 
Table 2.4. Effects of maternal MP supplementation during late (d 100 to d 130) gestation on 
cellularity measurements of ovine fetal muscle 
 Treatment
1
   
Item MP60 MP100 MP140 SE
2
 P - value 
Longissimus `     
RNA, mg/g 2.08 2.32 2.07 0.10 0.13 
DNA, mg/g 0.67 0.79 0.60 0.05 0.09 
Protein, mg/g 87.34 80.89 83.94 6.60 0.39 
Protein:DNA 132.31 105.79 139.32 12.41 0.40 
RNA:DNA 3.16 2.97 3.49 0.18 0.38 
Dry matter, % 16.86 17.42 17.13 0.41 0.28 
Semimembranosus      
RNA, mg/g 1.82 2.12 2.17 0.08 0.06 
DNA, mg/g 0.58 0.71 0.78 0.06 0.42 
Protein, mg/g 50.72 55.15 54.47 2.05 0.34 
Protein:DNA 98.79 77.62 70.53 9.87 0.48 
RNA:DNA 3.56 2.99 2.82 0.40 0.83 
Dry matter, % 17.19 17.14 17.26 0.28 0.80 
Psoas Major      
RNA, mg/g 2.55 2.89 2.28 0.30 0.65 
DNA, mg/g 0.65 0.81 0.60 0.09 0.57 
Protein, mg/g 92.11 82.80 84.47 9.82 0.90 
Protein:DNA 146.35 102.29 176.68 22.58 0.26 
RNA:DNA 3.97 3.58 4.52 0.49 0.71 
Dry matter, % 17.13 18.05 18.57 0.57 0.48 
1
Ewes fed 60% (MP60), 100 % (MP100), or 140% (MP140) of MP requirements during late 
gestation (NRC, 2007). 
2
Standard error of the means for MP60, n = 6; MP100, n = 6; and MP140; n = 6. 
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Conclusion 
Maternal nutrition has many theoretical implications for offspring because of its 
influence on the nutrients available to the uteroplacenta and consequently the developing 
conceptus.  The nutrient supply available to the fetus could greatly affect not only the 
development of the animal in utero, but also the developmental programming of the growing 
lamb when it reaches the external environment. Any possible means to improve nutrient 
acquisition by the dam could improve nutrient availability for offspring. Further research is 
needed to determine if the fetus received differing diets. Our data on fetal growth suggest that 
supplementing ewes with MP during late gestation could increase lamb nutrient efficiency, thus 
better preparing them for the external environment and productive efficiency as a mature animal. 
In summary, fetal organ mass and skeletal muscle growth were sensitive to maternal MP 
during late gestation. Late-gestational MP also influenced ewe BW, body composition, and BUN 
level. Our results show that maternal supplementation with MP in isocaloric diets altered 
potential energy reserves of the fetus, but did not seem to have an obvious effect on BW change 
of lambs. The MP supplementation has some beneficial effects and needs further research on 
potential benefits in field production. 
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CHAPTER 3. PROTEOMIC ANALYSIS OF FETAL OVINE SKELETAL 
MUSCLE AS INFLUENCED BY MATERNAL METABOLIZABLE PROTEIN 
SUPPLEMENTATION IN LATE PREGNANCY 
Abstract 
The objective of the study was to identify proteins in ovine longissimus dorsi (LM) 
muscle in offspring as influenced by maternal metabolizable protein (MP) in late pregnancy. 
Two-dimensional difference in-gel electrophoresis (2D DIGE) coupled with mass spectrometry 
(MS) was used to compare the sarcoplasmic and myofibrillar protein fractions from fetal skeletal 
LM samples from dams fed either 60% (MP60), 100% (MP100), or 140% (MP140) of MP 
requirements during late (d 100 to d 130) gestation. On d 130 of gestation ewes were euthanized 
and LM samples were collected from fetuses. Skeletal muscle samples were analyzed using an 
immobilized pH 3 to 10 gradient (IPG) in the first dimension, followed by running proteins in 
their second dimension by SDS-PAGE. Mass spectrometry analyses with matrix-assisted laser 
desorption/ionization –time of flight (MALDI-TOF/TOF) was performed on in-gel spots of 
interest to identify proteins. Peptide identifications with ˃ 95% probability and protein 
identifications with ˃ 99% probability with at least two identified unique peptides were accepted. 
Thirty spots from the sarcoplasmic fraction and 12 spots from the myofibrillar fraction were 
selected for further identification by MS. Of these, there were 7 spots in the sarcoplasmic 
fraction corresponding to 5 proteins, respectively (tubulin beta-5 chain, alpha-enolase, creatine 
kinase m-type, fructose-bisphosphate aldolase [aldolase A], and phosphoglucomutase) and zero 
spots in the myofibrillar fraction that differed in relative abundance (P ≤ 0.10) among MP 
treatments. Further analysis by Western Blotting was performed for aldolase A in the 
sarcoplasmic fraction and troponin-T (TnT) in the myofibrillar fraction. Aldolase A in the LM of 
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fetuses from MP140 and MP60 ewes was more abundant (P = 0.05) compared with those from 
MP100 supplemented ewes. The use of these methods in order to study fetal ovine skeletal 
muscle development resulted in the identification of many high abundant proteins, including 
many plasma proteins. Further investigation into prefractionation or other methods of in-gel 
sample preparation must be considered in order to look more closely at low abundant proteins 
that may have been masked during this experiment. 
Keywords: late gestation, mass spectrometry, maternal nutrition, metabolizable protein, 
proteomics, sheep 
Introduction 
There is substantial evidence that maternal nutritional status is one of the extrinsic factors 
programming nutrient partitioning and ultimately growth and development of the fetus (Wallace, 
1948; Wallace et al., 1999; Godfrey and Barker, 2001; Strickland et al., 2004; Wu et al., 2006). 
Current literature suggests that balancing diets for metabolizable protein (MP) supply is a more 
accurate reflection of true protein needs of ruminants than using digestible protein (DP) or crude 
protein (CP). In brief, MP is a combination of dietary and microbial protein that is digested 
postruminally and from which amino acids are absorbed from the intestine (NRC, 2007). 
Previous data with protein supplementation during gestation has shown that maternal under-
nutrition can significantly reduce the number of muscle fibers and nuclei in the offspring (Bedi et 
al., 1982; Wilson et al., 1988; Ward and Stickland, 1991). Altering the maternal diet before 
muscle fiber formation also changes the muscle fiber development of the fetus. Fahey and others 
(2005) found decreased maternal nutrition before fiber formation (d 30 through d 70) results in 
lambs with fewer myosin heavy-chain fast fibers and more myosin heavy-chain slow fibers in the 
LM, while maternal undernutrition during other periods of pregnancy had no effect on the 
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number of muscle fibers in newborn lambs. Two-dimensional DIGE allows simultaneous 
separation of thousands of proteins. Current research using this method to study sarcoplasmic 
and myofibrillar protein fractions in skeletal muscle is limited, but these fractions contain the 
majority of proteins involved in metabolism and signal transduction pathways which are of 
interest in understanding regulatory mechanisms (Hamelin et al., 2006). 
The aim of the present study was to develop a method to study and identify proteins from 
fetal skeletal muscle that may be differentially expressed by different levels of maternal MP 
supplementation during late gestation using 2D DIGE and MS. This type of approach allowed us 
to establish an ovine skeletal muscle protein map using an IPG of 3-10, which is an important 
step in applying proteomic analysis to the field of animal science. 
Materials and Methods 
Experimental Design 
Rambouillet ewes were transported to the Animal Nutrition and Physiology Center 
(ANPC) in Fargo, North Dakota, in July of 2011. Upon arrival ewes were synchronized for 
estrus using progesterone inserts (CIDR, Pfizer Animal Health, New York, NY) for 7 d. Initially, 
52 ewes were divided evenly into 4 separate pens with ad libitum access to hay and water. Ewes 
were mated with rams of proven fertility equipped with mating harnesses and marking crayons to 
obtain mating dates. Mating was recorded every 12 h. Pregnancy was confirmed and embryos 
were enumerated at 32 ± 4 d post-breeding via trans rectal ultrasonography (Aloka SSD-3500; 
Aloka America, Wallingford, CT) with a 7.5 MHz, linear trans-rectal probe, as described by 
Schrick and Inskeep (1993). Ewes carrying multiple conceptuses were administered 20 mg of 
Lutalyse intramuscularly (Pfizer Animal Health, New York, NY) and reintroduced to the rams 2 
wk later. . On d 90 of gestation dams carrying singleton pregnancies (n = 18) were housed in 
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individual pens (0.91 x 1.2 m) at ANPC for the remainder of the experiment. All dams were 
acclimated to a common diet (Refer to Chapter 2; Table 2.1) and ad libitum access to water. 
Diets were analyzed for DM, ash, and CP following AOAC (1990), and NDF and ADF using an 
Ankom Fiber Analyzer (Ankom Technology, Fairport, NY). 
Metabolizable protein treatments began on d 100 of gestation. Dams were supplemented 
with 140% of the MP requirement (MP140), 100% of the MP requirement (MP100), and 60% of 
the MP requirement (MP60). Diets were isocaloric and balanced to meet the energy requirements 
of 70-kg mature ewes bearing singletons (NRC, 2007). Metabolizable protein requirements were 
based on the CP requirements of a ewe consuming a 40% RUP ration (NRC, 2007). 
Metabolizable protein supplied was calculated as: MP (g/d) = (CP, g/d × (64 + (0.16 × UIP of 
ration)))/100. To account for variability in nutrient concentration of DDG and other diet 
constituents, feedstuffs were analyzed for nutrient density just prior to the start of the treatment 
period. Ewes were blocked by BW into 1 of 3 treatments and housed individually (MP60, n = 6; 
MP100, n = 6; MP140, n = 6) and weighed every 7 d to adjust the rations of MP supplement and 
corresponding hay for changes in BW throughout the experiment. All ewes were individually 
offered respective MP supplement. The hay portion of the diet was given to the ewes shortly 
after all had consumed the MP supplement. 
Collection of Muscle Sample 
Eighteen Rambouillet ewes were euthanized by exsanguination after stunning with 
captive bolt at ANPC on d 130 of gestation. Longissimus dorsi muscles were removed from the 
fetus, frozen in liquid nitrogen, and stored at -80˚C until analysis. 
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Extraction of Sarcoplasmic Fraction 
The highly soluble sarcoplasmic fraction was extracted from the snap frozen LM 
samples. Approximately 1.5 g of muscle was homogenized in low ionic strength sarcoplasmic 
extraction buffer [50 mM Tris, 1 mM ethylenediaminetetraacetic acid (EDTA); pH 8.5 (LISS); 
Anderson et al., 2012] with a Polytron (Brinkmann, Westbury, NY). Samples were then 
centrifuged at 21,100 × g for 30 min at 4˚C. The supernatant (sarcoplasmic protein fraction) was 
then decanted (using a transfer pipet) into 15-mL polypropylene conical tubes and the protein 
concentration was determined using the Quick Start Bradford Protein Assay (Bio-Rad 
Laboratories, Hercules, CA; Bradford et al., 1976). The pellet (myofibrillar protein fraction) was 
saved on wet ice until ready to process. The protein concentration of the sarcoplasmic fraction 
was adjusted to 6 mg/mL using cold LISS, separated into 0.5 mL aliquots, and stored at – 80˚C 
until analysis. 
Extraction of Myofibrillar Fraction 
To each pellet (myofibrillar protein fraction) saved previously, 5.0 mL of cold LISS was 
added (washing step) and samples were then centrifuged at 21,000 × g for 30 min at 4˚C. The 
supernatant was then discarded using a transfer pipet and the LISS washing step was repeated. 
The supernatant was then discarded and 10 mL of warm (≤ 37˚C) myofibrillar solubilizing buffer 
[8.3 M urea, 2 M thiourea, 2% (wt/vol) 3-[(3-cholamidopropyl) dimethyl-ammonia] -1- 
propanesulfonate (CHAPS), pH 8.5 (MSB); Bjarnadottir et al., 2011] was added to the 
myofibrillar protein fraction. The tubes were then vortexed and incubated in a warm water bath 
(≤ 37˚C) for 30 min. Each pellet was homogenized with a Polytron (Brinkmann, Westbury, NY) 
and centrifuged at 21,000 × g for 30 min at 25˚C. The supernatant was then transferred (using a 
transfer pipet) to a 15-mL polypropylene conical tube and stored at room temperature until same-
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day protein concentration determination with the Quick Start Bradford Protein Assay (Bio-Rad 
Laboratories, Hercules, CA; Bradford et al., 1976). The protein concentration of the myofibrillar 
fraction was adjusted to 5 mg/mL using cold extraction buffer, separated into 0.5 mL aliquots, 
and stored at – 80 ˚C until analysis. 
Two-Dimensional Difference In-Gel Electrophoresis (2D DIGE) and Data Analysis 
The sarcoplasmic and myofibrillar fractions of fetal ovine LM from ewes fed MP 
treatments throughout late gestation were further analyzed by 2D DIGE in order to observe the 
difference in protein expression among treatments. First, an internal standard for each 
(sarcoplasmic and myofibrillar) fraction was created using a pooled sample representative of the 
samples used in the study and ran as a standard labeled with Cy2 for all gels (Rozanas & 
Loyland, 2008; Westermeier & Scheibe, 2008). Then, samples from both fractions were labeled 
with Cy dyes according to the trials designed for the experiment (Table 3.1) and the 
manufacturer’s directions (GE Healthcare, Piscataway, NJ). 
Combinations of 15 µg of protein from the MP60 (Trial 2) or MP140 (Trial 1), 15 
micrograms from the MP100, and 15 micrograms from internal standard were loaded on each 
IPG strip (pH 3 to 10) for a total of 45 µg of protein per strip (Table 3.1; Figure 3.1). Samples 
from the three treatments (MP60, MP100, and MP140) were labeled alternately with Cy3 and 
Cy5 to avoid a labeling bias. Two trials were created among the 3 treatments (Table 3.1). Trial 1 
compared MP140 (n = 6) to MP 100 (n = 6), and Trial 2 compared MP60 (n = 6) to the same 
MP100 (n = 6) lamb LM samples from Trial 1. Trials 1 and 2 were run for both the sarcoplasmic 
and myofibrillar fractions, and duplicate strips were run to minimize variation (24 sarcoplasmic 
+ 24 myofibrillar = 48 total IPG strips in the experiment). 
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Separation of proteins in the first dimension by isoelectric point (pI) was accomplished 
using Immobiline DryStrips (11 cm, pH 3-10, GE Healthcare, Piscataway, NJ) containing 2.5 
mM DL-dithiothreitol (DTT). Focusing of proteins on IPG strips was performed on an Ettan 
IPGphor 3 isoelectric focusing system (GE Healthcare, Piscataway, NJ). Initially, a low voltage 
(500 V) was applied, followed by a stepwise increase to 8000 V to reach a total of 18,500 V 
hours. After isoelectric focusing, strips were equilibrated for 15 min in 10 mL of equilibration 
buffer (50 mM tris pH 8.8, 6 M urea, 30% (vol/vol) glycerol, 2% (wt/vol) SDS, and a trace of 
bromophenol blue) containing 65 mM DTT. This was followed by an equilibration for 15 min in 
10 mL of equilibration buffer containing 135 mM iodoacetamide (Rozanas and Loyland, 2008).  
 
Table 3.1. Cy dye labeling
1
 of 2-dimensional difference in gel electrophoresis comparison of 
MP60, MP100, and MP140 fetal ovine LM samples 
Strip Cy 2 Cy3 Cy5 
 Trial 1 
1 Standard
2
 MP100
3
 MP140 
2 Standard MP140 MP100 
3 Standard MP100 MP140 
4 Standard MP140 MP100 
5 Standard MP100 MP140 
6 Standard MP140 MP100 
 Trial 2 
1 Standard MP100 MP60 
2 Standard MP60 MP100 
3 Standard MP100 MP60 
4 Standard MP60 MP100 
5 Standard MP100 MP60 
6 Standard MP60 MP100 
1
Trials 1 and 2 were run for both myofibrillar and sarcoplasmic protein fractions  
2
Standard = pooled sample created for each protein fraction representative of all samples used 
in the study. 
3
Maternal diets (DM basis) were balanced for mature ewes baring singletons during the last 4 
weeks of gestation according to NRC (2007). Treatments: MP60 = 60% of MP requirements, 
MP100 = 100% of MP requirements, MP140 = 140% of MP requirements. 
  
 
5
6
 
  
Figure 3.1. Two-Dimensional In-Gel Electrophoresis (2D DIGE). Sample preparation for 2D PAGE. Adapted from Posch, A. 2007. 
Methods in Molecular Biology. 
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Second dimension electrophoresis (separation by molecular weight using SDS-PAGE) 
was run on 12.5% acrylamide gels (acrylamide: N,N’-bis-methylene acrylamide = 100:1 [wt/wt], 
0.1%SDS [wt/vol], 0.05% N,N,N’,N-tetramethylethylenediamine (TEMED), 0.05% 
[wt/vol]ammonium persulfate, and 0.5 M Tris, pH 8.8) with a SE 600 vertical slab gel unit 
 (Hoefer Scientific Instruments, Holliston, MA). Two strips were placed side-by-side on the top 
of each gel and run at a constant of 120 V until tracking dye had just run off completely. Gels 
were then imaged on an Ettan DIGE Imager (GE Healthcare, Picataway, NJ) with 3 images for 
each strip gel area (Cy2, Cy3, and Cy5, respectively). All images were uploaded into DeCyder 
2D Software (v. 6.5; GE Healthcare, Piscataway, NJ) and analyzed to identify differences 
between MP treatments in relative abundance of individual spots. 
After analysis of all spots was completed using DeCyder, a last set of gels i.e., pick gels 
were poured in order to manually pick gel spots for further protein identification and analysis by 
MS. Pick gels were 12.5% acrylamide gels (acrylamide: N,N’-bis-methylene acrylamide = 100:1 
[wt/wt], 0.1 %SDS [wt/vol], 0.05% TEMED, 0.05% [wt/vol] ammonium persulfate, and 0.5 M 
Tris, pH 8.8) run on a Hoefer SE 600 Ruby unit (Hoefer Scientific Instruments, Hollison, MA). 
Four Immobiline IPG strips for pick gels were prepared as previously described, but with a load 
of 500 µg of pooled unlabeled protein from all 3 treatment samples (MP60, MP100, and MP140) 
combined. IPG strips were focused in the first dimension as previously described. For second 
dimension electrophoresis, two duplicate pick gels were run on each fraction (2 sarcoplasmic and 
2 myofibrillar, respectively) at 100 V until tracking dye had just run off. After second dimension 
electrophoresis, pick gels (total of 4) were stained with colloidal coomassie blue solution (1.7% 
[wt/vol] ammonium sulfate, 30% [vol/vol] methanol, 3% [vol/vol] phosphoric acid, and 0.1% 
[wt/vol] Coomassie G-250 for 24 h, followed by destaining for up to 4 h. Proteins of interest and 
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those previously determined by differences detected in comparison studies using the DeCyder 
2D software were manually excised from the gel, placed into individual snap cap tubes, and 
stored at -80˚C until digestion and identification by MS. 
In-Gel Protein Digestion 
Spots were destained and in-gel trypsin digested by standard laboratory protocol 
(Shevchenko et al., 1996). Gel spots were destained and proteins were reduced in-gel with 4 mM 
DTT in 50 mM ammonium bicarbonate for 15 min at 60˚C. Iodoacetamide was added to make 
16 mM and alkylation was allowed to proceed for 30 min at room temperature in the dark. The 
reaction was quenched with an additional 3 mM DTT. The gel spot was then equilibrated with 55 
mM ammonium bicarbonate, dehydrated with 100% acetonitrile, and rehydrated in 0.02 µg 
Trypsin Gold (Promega) in 40 mM ammonium bicarbonate. Digestion was allowed to proceed 
overnight at 37˚C. Approximately 50 µL of peptides were extracted. The samples were acidified 
with formic acid to make 0.1% final concentration.  
Manual Spot Analysis 
A subset of spots was initially analyzed by manual spotting. Peptides from these samples 
were captured by C18 solid-phase extraction using Zip-Tips by passing 13 µL through the tip. 
The remaining partially depleted sample was retained and stored at -80˚C. The recovered 
peptides were eluted and 0.5 µL was mixed with an equal volume of 10 mg/ml of a-
cyanohydroxy cinammic acid (CHCA) in 75% [vol/vol] acetonitrile/0.1% formic acid and 
spotted onto a MALDI target. Samples were analyzed using an AB 4800 MALDI TOF/TOF. Top 
20 MS precursors were selected and analyzed by MSMS from weakest to strongest. The 
remaining spots were analyzed by manual spotting as above except the half of the samples that 
were removed previously for LC-TEMPO analysis. 
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LC-TEMPO Analysis 
This method is also described in EW004. Samples were analyzed by reverse phase high 
performance liquid chromatography (rpHPLC) and spotted onto a MALDI target plate using a 
TEMPO-LC integrated nanoflow HPLC/spotter. A total of 8.8 µL of sample was injected onto a 
Proteocol C18 0.3 c 10 mm trap (3 µm, 300A pore size). The samples were desalted with 2% 
acetonitrile/formic acid (vol/vol) for 10 min at a flow rate of 10 µL/min. Peptides were eluted in-
line through a 0.1 x 100 mm Magic AQ C18 (5 µm) column using a 30 m gradient from 100% 
Buffer A to 60% Buffer A, /40% Buffer B (98% [vol/vol] acetonitrile, 0.1% [vol/vol] formic 
acid) at a flow rate of 1 µL/min. Eluate was mixed post-column with an equal volume of 10 
mg/ml CHCA in 75% [vol/vol] acetonitrile and 0.1% [vol/vol] formic acid. The matrix/eluent 
mix was spotted at 18 sec/spot. The column was regenerated at 70% (vol/vol) acetonitrile/0.1% 
formic acid. 
Protein Isolation and Identification by Mass Spectrometry 
Spot sets were analyzed on the AB4800 MALDI TOF/TOF in reflector positive ion 
mode. For MS the m/z range was 800 to 4000. A total of 400 subspectra were accumulated per 
spectrum. For MSMS, the top 10 precursors were selected per spot with the weakest precursor 
first. A total of 600 subspectra were accumulated per MSMS spectrum.  
Raw spectra were converted to T2D files using 4000 series Explorer 3.5.28193. The file 
extension T2D stands for technology transfer database; a binary format data file that is exported 
from an Oracle database. These files were converted to Mascot generic format (mgf) files using 
Peaks to Mascot. All spectra were searched with Mascot (v. 2.3.02, Matrix Science) against the 
Universal Protein resource (UniProt) database (v., May 5, 2012) restricted to the bovine 
complete proteome, human complete proteome, or the sheep proteome. The latter was 
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incomplete and contained many sequence fragments. The search parameters were trypsin with up 
to one missed cleavage, carbamidomethyl (N-term C), Gln˃pyro-Glu (N-term Q), Oxidation 
(M). Mass values were monoisotopic, peptide mass tolerance was 100 ppm, and fragment ion 
tolerance was 0.5 Da. Mascot searches were combined and analyzed in Scaffold (v. 3.00.08) to 
validate peptide and protein identifications. Each spot was treated as a biological replicate. This 
permitted spot-to-spot comparison which helped to flag some identifications as carry-over 
contaminants from proceeding runs. Peptide identifications with ˃ 95% probability and protein 
identifications with ˃ 99% probability and at least two identified peptides were accepted. 
SDS-PAGE and Western Blotting 
Wang’s protein extracts for gel electrophoresis were prepared using methods described 
by Huff-Lonergan et al. (1996) and Wang (1982), utilizing the modified 3x Wang’s Sample Gel 
Buffer/Tracking Dye [3 mM EDTA; 3% (wt/vol) SDS; 30% (vol/vol) glycerol; 0.003% (wt/vol) 
pyronine Y; 30 mM Tris, pH 8.0]. The sarcoplasmic protein fraction was used in LISS and the 
myofibrillar fraction was used in MSB. 
SDS-PAGE Electrophoresis 
Samples in sample buffer/tracking dye (sarcoplasmic fraction in LISS and myofibrillar 
fraction in MSB) for aldolase A and TnT, respectively, were run on 12.5% acrylamide separating 
gels (acrylamide: N, N’-bis-methylene acrylamide = 37.5:1 [wt/wt], 0.1% [wt/vol] SDS, 0.05% 
(TEMED), 0.05% [wt/vol] ammonium persulfate, and 0.37 M Tris, pH 8.8) with 5% acrylamide 
stacking gels (acrylamide: N, N’-bis-methylene acylamide = 37.5:1 [wt/vol], 0.1% [wt/vol] SDS, 
0.125% TEMED, 0.075% [wt/vol] ammonium persulfate, and 0.125 M Tris, pH 6.8) in a running 
buffer [25 mM Tris, 192 mM glycine, 1.7 mM EDTA, 0.1% [wt/vol] SDS] (Melody, et al., 
2004). Electrophoresis was carried out on a BioRad Mini-PROTEAN Tetra Cell system (BioRad 
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Laboratories, PA). Gels for TnT were loaded with 7 µg of protein per lane and run at a constant 
voltage of 100 V for 3 h. Gels for aldolase A were loaded with 10 µg of protein per lane and run 
at a constant voltage of 100 V for 3.5 h.  
Transfer Conditions  
Proteins were transferred onto Millipore Immobilon-P polyvinylidene Diflouride transfer 
membrane (Millipore Corporation, Bedford, MA) using a TE22 Might Small Transphor 
electrophoresis unit (Hoefer Scientific Instruments; Holliston, MA) at a constant voltage of 90 V 
for 1.5 h. In a buffer [25mM Tris, 1.9 M glycine, 0.017 M EDTA, and 15% (vol/vol) methanol] 
maintained at 4˚C using a refrigerated circulating water bath. 
Western Blotting 
Post transfer, all membranes were blocked in PBS-Tween [80 mM disodium hydrogen 
orthophosphate, 100 mM sodium chloride, 0.1% (vol/vol) polyoxyethylene sorbitan monolaurate 
(Tween-20), and 5% (wt/vol) nonfat dry milk] for 1 h at room temperature (23˚C). After 
blocking, membranes were placed in their respective primary antibody diluted with PBS-Tween. 
Troponin-t blots were incubated overnight at 4˚C with the primary antibody (mouse monoclonal 
anti-rabbit troponin-T antibody, catalog No. T6277; Sigma Chemical Co., St. Louis MO) diluted 
1:30,000. For aldolase A, the primary antibody (mouse monoclonal anti-human ALDOA 
antibody, catalog No. 226-M01; Abnova Antibodies, Taiwan) was diluted to 1:20,000 and 
incubated overnight at 4˚C. After primary antibody incubations were complete, membranes were 
allowed to warm to room temperature (23˚C) for 20 min and washed 3 times (10 m/wash) using 
PBS-Tween. Both TnT and aldolase A blots were incubated 1 h at room temperature with the 
secondary antibody (goat anti-mouse conjugated with horseradish peroxidase, Catalog No. 
A2554; Sigma Chemical Co.) diluted at 1:45,000. After completion of secondary antibody 
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incubation, all membranes were washed 3 times (10 m/wash) with PBS-Tween at room 
temperature (23˚C) to achieve a total wash rinse time of 30 min before chemiluminescence 
detection (Melody et al., 2004). Chemiluminescence was initiated using premixed reagents (ECL 
Prime kit; Amersham Pharmacia Biotech, Pascataway, NJ). Chemiluminescence was detected 
using a F2.8 28-70 mm zoom lens camera (Alpha Innotech Corp.). Densitometry measurements 
were completed using the AlphaEaseFC software (Alpha Innotech Corp.). 
Western Blotting Statistics 
Troponin-T and Aldolase A Western blot data were analyzed using GLM procedure in 
SAS (v.9.2; SAS Inst., Inc., Cary, NC) to determine differences between MP treatments. Least 
squares means were separated using the PDIFF option. The ratio of the intensity of the sample 
band to the intensity of the same band in control sample was used to analyze differences in 
aldolase A in the sarcoplasmic fraction of fetal LM between maternal MP treatments. The ratio 
of the intensity of the sample band to the intensity of the same band in the control sample was 
used to analyze differences in TnT isoforms in the myofibrillar fraction of fetal LM between 
maternal MP treatments 
Results and Discussion 
Two-Dimensional In-Gel Electrophoresis 
Results from this study using 2D DIGE and Western blot analysis showed that 
differential expression of fetal muscle proteins occurred as a result of maternal MP 
supplementation in late gestation. In a first approach, an attempt to get an overview of protein 
expression in the LM of fetal ovine from ewes supplemented or restricted in MP throughout late 
gestation was made. For this purpose, two 2D DIGE pick gel maps of the sarcoplasmic and 
myofibrillar fractions (500 µg protein load) of LM (Figures 3.4 and 3.5, respectively) are 
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presented. These figures display the separation of proteins over the entire range of the pH 3 to 10 
strip for each fraction, respectively. Using the DeCyder 2D software, background was subtracted 
from each image and spots were detected and matched across gels of the same trial, followed by 
spot volume normalization with the standard. Observations of the multiple repeat 2D DIGE gels 
showed that spot locations and intensities were highly similar between gels from the same 
sample. Approximately 300 spots were detected and compared in each gel for both sarcoplasmic 
and myofibrillar proteins. Thirty spots from the sarcoplasmic fraction and 12 spots from the 
myofibrillar fraction were selected for further identification by MS. The Scaffold proteome 
software used to analyze MS results also has the ability to categorize these proteins into their 
biological processes and cellular components (Figures 3.2 and 3.3). Of these, there were 6 spots 
in the sarcoplasmic fraction and 0 spots in the myofibrillar fraction that differed in relative 
abundance (P ≤ 0.10) among MP treatments. The complete sheep proteome has yet to be 
sequenced, and the remaining spots were chosen because they were prominent on the pick gel 
and therefore of particular interest to the current study on fetal ovine skeletal muscle growth. 
The separation of proteins on 2D gels and peptide mass fingerprint analyses allowed us to 
identify different classes of proteins. Proteins were divided into the following groups: energy 
metabolism, contractile apparatus, cell structure, cell defense, regulator, and other (Tables 3.2 
and 3.3). The proteins identified, along with their associated molecular weight (MW) and pI are 
presented. Although there were no MW markers on Figures 3.4 and 3.5, the pH range is 
displayed. Also listed for each identified protein are the number of unique peptides and total 
sequence coverage, respectively, from MS analysis. As stated previously, a sample was required 
to have at least two unique peptides upon analysis to be considered. The identified proteins from 
the sarcoplasmic protein fraction are listed in Table 3.2. Eight were associated with energy 
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metabolism and matched to 6 different proteins: triosphosphate isomerase (2 spots), alpha-
enolase, creatine kinase M-type, aldose reductase, glyceraldehyde-3-phosphate dehydrogenase (2 
spots), and carbonic anhydrase. Tropomyosin beta chain was the only protein identified in the 
contractile apparatus category. Ten were associated with cell structure and matched to five 
different proteins: tubulin alpha-1B chain, tubulin alpha-4A chain, tubulin beta-5 chain, 
vimentin, actin (cytoplasmic), actin (alpha skeletal muscle), desmin, and aldolase A. Two heat 
shock proteins (HSP), HSP beta-1 and HSP 90-beta, were sorted into the cell defensive category. 
Four spots were categorized as regulatory and matched to 4 different proteins: alpha-1 
antiproteinase, beta-enolase, poly(rC)-binding protein 1, and 14-3-3 protein gamma. Seven spots 
matched to 5 other proteins were also identified: endoplasmin, alpha-2-HS-glycoprotein, 
serotransferrin, serum albumin, and phosphoglucomutase-1. 
Table 3.3 shows the proteins identifies in the myofibrillar fraction. Five were associated 
with energy metabolism and matched to 4 different proteins: creatine kinase M-type, AZP 
synthase subunit beta, fructose-bisphosphate aldolase, and glyceraldehyde-3-phosphate 
dehydrogenase. Four proteins related to contractile apparatus were matched to 5 spots: 
tropomyosin alpha-1 chain, tropomyosin beta chain, troponin-T, and myosin light chain. Two 
spots were linked to cell structure and matched to 2 proteins; actin and desmin. An additional 
protein identified was a probable C->U editing-enzyme APOBEC-2.  
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Figure 3.2. Biological processes of identified proteins as determined by Scaffold proteome 
software. 
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Figure 3.3. Cellular components of identified proteins as determined by Scaffold proteome 
software. 
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Figure 3.4. Representative two-dimensional difference in-gel electrophoresis map of fetal ovine 
LM sarcoplasmic proteins. Abbreviations: ACTA1 = Actin, alpha skeletal muscle; ACTB = 
Actin, cytoplasmic; AHSG = Alpha-2-HS-glycoprotein; AKR1B1 = Aldose reductase; ALDOA 
= Fructose-bisphosphate aldolase; BSA = Serum albumin; CA3 = Carbonic anhydrase 3; CKM = 
Creatine kinase M-type; DES = Desmin; ENO1 = Enolase 1; ENO3 = Enolase 3; GAPDH = 
Glyceraldehyde-3-phosphate dehydrogenase; GRP-94 = Endoplasmin; HSPB1 = Heat shock 
protein beta-1; HSP90AB1 = Heat shock protein HSP 90-beta; PCBP1 = Poly(rC)-binding 
protein 1; PGAM1 = Phosphoglucomutase-1; SERPINA1 = Alpha-1-antiproteinase; TBA1B = 
Tubulin alpha-1B chain; TF = Serotransferrin; TPI1 = Triosephosphate isomerase; TPM2 = 
Tropomyosin beta chain; TUBA4A = Tubulin alpha-4A chain; TUBB5 = Tubulin beta-5 chain; 
VIM = Vimentin; YWHAG = 14-3-3 protein gamma. 
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Figure 3.5. Representative two-dimensional difference in-gel electrophoresis map of fetal ovine 
LM myofibrillar proteins. Abbreviations: ABEC2 = Probable C-˃U-editing enzyme APOBEC-2; 
ACTA1 = Actin, alpha skeletal muscle; ALDOA = Fructose-bisphosphate aldolase; ATP5B = 
ATP synthase subunit beta, mitochondrial; CKM = Creatine kinase M-type; DES = Desmin; 
GAPDH = Glyceraldehyde-3-phosphate dehydrogenase; MYL1 = Myosin light chain 1/3, 
skeletal muscle isoform; Tnnt3 = Troponin T fast skeletal muscle type; TPM1 = Tropomyosin 
alpha-1 chain; TPM2 = Tropomyosin beta chain. 
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Table 3.2. Summary of protein identification from the sarcoplasmic fraction of fetal ovine LM 
Spot ID  
SWISS-PROT 
accession number
1
 
Protein name
1
 
MW, kDa 
theoretical 
pI 
theoretical 
Unique 
peptide 
Sequence 
coverage, % 
Energy metabolism      
6 TPIS_BOVIN Triosphosphate isomerase  27 6.45 10 50 
192 ENOA_BOVIN Alpha-enolase 47 6.37 6 29 
308 KCRM_BOVIN Creatine kinase M-type 43 6.63 22 48 
342 Q5E962_BOVIN Aldose reductase 36 5.88 14 42 
356 G3P_BOVIN Glyceraldehyde-3-phosphate dehydrogenase 36 8.51 16 44 
351 G3P_BOVIN Glyceraldehyde-3-phosphate dehydrogenase 36 8.51 15 44 
364 CAH3_BOVIN Carbonic anhydrase 3 29 7.71 13 58 
439 TPIS_BOVIN Triosephosphate isomerase 27 6.45 18 75 
Contractile apparatus      
311 TPM2_BOVIN Tropomyosin beta chain 33 4.66 12 37 
Cell structure      
164 TBA1B_BOVIN Tubulin alpha-1B chain 50 4.94 19 39 
164 TBA4A_BOVIN Tubulin alpha-4A chain 50 4.93 4 39 
181 TBB5_BOVIN Tubulin beta-5 chain 50 4.78 16 40 
204 VIME_BOVIN Vimentin 54 5.05 13 32 
216 VIME_BOVIN Vimentin 54 5.05 13 26 
280 ACTB_BOVIN Actin, cytoplasmic 42 5.29 17 45 
280 ACTS_BOVIN Actin, alpha skeletal muscle 42 5.23 6 45 
302 DESM_BOVIN Desmin 54 5.21 28 49 
315 A6QLL8_BOVIN Fructose-bisphosphate aldolase 39 8.45 22 71 
317 A6QLL8_BOVIN Fructose-bisphosphate aldolase 39 8.45 15 43 
Cell defensive      
3 E1BEL7_BOVIN Heat shock protein beta-1 23 5.77 7 37 
4 HS90B_BOVIN Heat shock protein HSP 90-beta 83 4.96 16 20 
1
Protein names and accession numbers were taken from the UniProt database (http://www.uniprot.org). 
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Table 3.2. Summary of protein identification from the sarcoplasmic fraction of fetal ovine LM (continued) 
Spot ID  
SWISS-PROT 
accession number
1
 
Protein name
1
 
MW, kDa 
theoretical 
pI 
theoretical 
Unique 
peptide 
Sequence 
coverage, % 
Regulator      
2 A1AT_BOVIN Alpha-1-antiproteinase 46 6.05 8 16 
217 ENOB_BOVIN Beta-enolase 47 7.60 23 44 
309 PCBP1_BOVIN Poly(rC)-binding protein 1 37 6.66 8 33 
353 1433G_BOVIN 14-3-3 protein gamma 28 4.80 5 25 
Other       
34 ENPL_BOVIN Endoplasmin  92 4.76 29 33 
87 FETUA_BOVIN Alpha-2-HS-glycoprotein  38 5.26 5 9.7 
105 G3X6N3_BOVIN Serotransferrin 78 7.13 18 23 
106 G3X6N3_BOVIN Serotransferrin 78 7.13 18 23 
132 ALBU_BOVIN Serum albumin 69 5.82 25 30 
376 PGAM1_BOVIN Phosphoglucomutase-1 61 6.75 18 38 
382 PGAM1_BOVIN Phosphoglucomutase-1 61 6.75 13 31 
1
Protein names and accession numbers were taken from the UniProt database (http://www.uniprot.org). 
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Table 3.3. Summary of protein identification from the myofibrillar fraction of fetal ovine LM 
Spot ID 
SWISS-PROT 
accession number
1
 
Protein name
1
 
MW, kDa 
theoretical 
pI 
theoretical 
Unique 
peptide 
Sequence 
coverage, 
% 
Energy metabolism       
2  KCRM_BOVIN Creatine kinase M-type 43 6.63 17 39 
173 KCRM_BOVIN Creatine kinase M-type 43 6.63 15 38 
123 ATPB_BOVIN ATP synthase subunit beta, mitochondrial 56 5.15 19 45 
168 A6QLL8_BOVIN Fructose-bisphosphate aldolase 39 8.45 12 37 
186 G3P_BOVIN Glyceraldehyde-3-phosphate dehydrogenase 36 8.51 2 9.3 
Contractile apparatus      
185  TPM1_BOVIN Tropomyosin alpha-1 chain 33 4.69 7 17 
217 TPM1_BOVIN Tropomyosin alpha-1 chain 33 4.69 17 48 
185 TPM2_BOVIN Tropomyosin beta chain 33 4.66 9 43 
210 Q8MKI0_BOVIN Troponin T fast skeletal muscle type 31 8.69 5 20 
303 MYL1_BOVIN Myosin light chain 1/3, skeletal muscle isoform 21 4.96 9 53 
Cell structure      
3 ACTS_BOVIN Actin, alpha skeletal muscle 42 5.23 18 54 
125 DESM_BOVIN Desmin 54 5.21 17 44 
Other      
246 ABEC2_BOVIN Probable C-˃U-editing enzyme APOBEC-2 26 4.84 5 17 
1
Protein names and accession numbers were taken from the UniProt database (http://www.uniprot.org). 
 
  
 71 
 
Functional Analysis of Differentially Expressed Proteins 
The proteins differentially expressed (P ≤ 0.05) between treatments are associated with 
energy metabolism and cell structure. Tubulin beta-5 chain was more abundant (P ˂ 0.05) in the 
LM of fetuses from ewes receiving the MP100 treatment when compared with those from MP60. 
In muscle cells, tubulin is a highly abundant structural protein essential for myotube formation. 
Although their function in skeletal muscle after differentiation is unclear, studies have been done 
to investigate the adaptation properties of tubulin in muscle (Sakurai et al., 2005). The results 
from the present study indicate decreased tubulin in LM in fetuses of dams receiving less than 
adequate protein, possibly hindering the muscle’s cytoskeletal ability to respond mechanically to 
the environment. 
The metabolic enzyme alpha-enolase was more abundant (P ˂ 0.05) in the LM of fetuses 
from MP60-treated ewes when compared with that from MP100 ewes. Apart from its role in 
glycolysis, recent assays have identified alpha-enolase as a novel protein capable of binding 
RNA (Hernández-Pérez et al., 2011). Identified in the rat myoblasts, alpha-enolase is present in 
the nucleus, suggesting the enzyme involvement in regulation, transport, or modification 
processes related to RNA (Hernández-Pérez et al., 2011). There is evidence from several studies 
demonstrating the role of alpha-enolase in glycolysis and transcriptional regulation (Merkulova 
et al., 1997; Keller et al., 2007; Jeffrey, 2009). The metabolic state of muscle cells and the 
localization of proteins to different cellular components during development of the LM in fetuses 
from MP60 ewes may have caused an increase in alpha-enolase expression when compared with 
fetuses from MP100 ewes. The protein profile of muscle from fetuses of dams receiving less than 
adequate amounts of protein may have been adversely affected, resulting in differential 
appearance of the glycolytic enzyme. 
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Creatine kinase was more abundant (P ˂ 0.05) in the LM of fetuses from ewes receiving 
the MP100 treatment when compared to the MP140 treatment. Creatine kinase is most 
commonly known for its ability to catalyze the reversible transfer of high energy phosphate from 
ATP to creatine. In muscle cells, this extra energy buffer plays a pivotal role in maintaining ATP 
homeostasis (Hettling, 2011). An enzyme with two different subunits, creatine kinase has been 
shown immunochemically to be expressed in a developmentally and tissue-specifically regulated 
manner (Robert et al., 1991). There are many proposed roles of creatine kinase in muscle 
including, regulation of phosphorylation, intracellular energy transport, transfer of phosphoryl 
groups via the phosphocreatine shuttle, and the ability to buffer ADP concentration in cytosol 
near sites of ATP hydrolysis. Adequate amounts of dietary protein or essential amino acids can 
increase muscle protein synthesis in healthy animals. In the present study, excess levels of 
maternal MP did not appear to enhance the glycolytic potential of fetal LM. A muscle creatine 
kinase deficiency could result in delay of postnatal muscle growth, impaired muscle regeneration 
and decreased muscle hypertrophy (Izumiya et al., 2008). 
We identified aldolase A in 2 spots at different pI on our 2D gel map. Analysis of these 2 
spots demonstrated the most alkaline spot was more abundant (P ˂ 0.01) in the LM of fetuses 
from MP140 ewes, while the remaining spot was more abundant (P ˂ 0.05) in the LM of fetuses 
from MP100 ewes. These data could be the result of a post-translational modification such as 
phosphorylation. Unfortunately, due to the fact that the sheep proteome in not sequenced, it is 
unclear what modification, if any, occurred. A study investigating nutritional status on muscle 
development in rabbits found that increased activity of aldolase A slowed down muscle 
development as a result of feed rationing (Zotte et al., 2004). Phosphoglucomutase 1 (PGM1) 
was more abundant (P ˂ 0.05) in LM from fetuses of ewes receiving the MP100 treatment when 
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compared with that from fetuses of ewes receiving the MP60 treatment. PGM1 catalyzes the 
interconversion of glucose-1-phosphate and glucose-6-phosphate via the glucose-1,6-
diphosphate intermediate, representing a key step in the glycolytic pathway (Levin et al., 1999). 
The growth potential of fetal skeletal muscle is dependent upon the increased expression of 
central enzymes involved in glycolysis (Bernard et al., 2009). Glycogen metabolism could be 
adversely affected by a decreased expression of PGM1 in fetuses of ewes receiving the MP60 
treatment. A decrease in this important enzyme may lead to reduced glucose availability to the 
fetus, resulting in slowed muscle turnover. 
Western Blotting 
The same protein can be identified in different spots and at different pI and MW locations 
within a muscle. Different locality of the same protein on gels maps could be consistent with 
different isoforms. Isoform expression can result from the expression of different genes or may 
also be initiated by post-translational modifications such as oxidation, glycosylation, 
phosphorylation, or proteolytic cleavage. Mass spectrometry analysis resulted in 2 spots at 
different locations and intensities identified as aldolase A. In a one-dimensional Western blot for 
aldolase A 2 immunoreactive bands were detected (Figure 3.5). The ratio of the intensity of the 
sample band to the intensity of the same band in control sample was used to analyze differences 
in aldolase A in the sarcoplasmic fraction of fetal LM between maternal MP treatments. 
Although we observed no effect of MP treatment on Band 1, Band 2 was more abundant 
(P = 0.05) in LM of fetuses from MP140 and MP60 ewes when compared to those from MP100 
supplemented ewes. This is in agreement with our results from 2D DIGE (Table 3.4). We suspect 
that immunoreactive Band 1 might be aldolase B since we cannot contribute it to non-specific 
binding. 
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Table 3.4. Identified proteins from proteomic analysis differentially expressed among MP treatments in sarcoplasmic fraction of fetal 
ovine LM 
Spot ID
1
 Name Comparison 
More 
abundant in 
P - value UniProt ID 
Theoretical 
MW (kDa) 
181 Tubulin beta-5 chain MP60 vs. MP100 MP100 0.016 TBB5_BOVIN 50 
192 Alpha-enolase MP60 vs. MP100 MP60 0.013 ENOA_BOVIN 47 
308 Creatine kinase M-type MP140 vs. MP100 MP100 0.016 KCRM_BOVIN 43 
315 Fructose-bisphosphate aldolase MP140 vs. MP100 MP140 0.002 A6QLL8_BOVIN 39 
317 Fructose-bisphosphate aldolase MP140 vs. MP100 MP100 0.014 A6QLL8_BOVIN 39 
376 Phosphoglucomutase 1 MP60 vs. MP100 MP100 0.018 PGAM1_BOVIN 61 
1
Spot name corresponds to spots identified in Fig. 3.2. 
2
Protein names and accession numbers were taken from the UniProt database (http://www.uniprot.org).
 
3
Maternal diets (DM basis) were balanced for mature ewes baring singletons during the last 4 weeks of gestation according to NRC 
(2007). Treatments: MP60 = 60% of MP requirements, MP100 = 100% of MP requirements, MP140 = 140% of MP requirements.
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Aldolase A, found in the developing embryo, is an enzyme that catalyzes a reversible 
aldol reaction during glycolysis. The increase in the glycolytic enzyme content seen in the LM of 
fetuses from MP140 and MP60 ewes may increase the volume of substrates through glycolysis. 
While providing adequate protein to the dam during gestation did not alter fetal aldolase A 
expression, fetal LM was sensitive to both high and low levels of maternal-supplemented MP, 
suggesting possible effects of maternal nutrition on fetal muscle glucose metabolism.  
In order to further examine whether maternal nutrition in utero affects myogenesis, TnT, 
a myofibrillar protein identified that is important to skeletal muscle development, was 
investigated. Troponin T binds to tropomyosin and helps position it on actin, regulating 
contraction of striated muscle. It has been shown to generate protein diversity by alternative 
RNA splicing in all striated muscles. Fast and slow skeletal TnT isoforms can be expressed from 
several different mRNA in a developmentally regulated and tissue-specific manner (Gomes et 
al., 2002). The role of these different TnT isoforms in the regulation of muscle contraction is not 
well understood. In a one-dimensional Western blot for TnT (myofibrillar protein fraction), 6 
bands were detected (Fig. 3.6). No effect of treatment was observed in Bands 1 to 5 of TnT 
analyzed from the myofibrillar fraction of ovine fetal LM. There was a tendency (P = 0.08) for 
Band 1 to be more abundant in the LM of fetuses from ewes receiving the MP140 treatment 
when compared with that of fetuses from MP60 ewes, with MP100 being intermediate.
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Figure 3.6. Representative aldolase A Western blot run on 12.5% acrylamide separating gel 
loaded with 10 µg of sarcoplasmic protein. Two major immunoreactive bands were detected. 
Maternal diets (DM basis) were balanced for mature ewes baring singletons during the last 4 
weeks of gestation according to NRC (2007). Treatments: MP60 = 60% of MP requirements, 
MP100 = 100% of MP requirements, MP140 = 140% of MP requirements. 
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Figure 3.7. Representative Troponin-T Western blot run on 12.5% acrylamide separating gel 
loaded with 7 µg of myofibrillar protein. Five major immunoreactive bands were detected. 
Maternal diets (DM basis) were balanced for mature ewes baring singletons during the last 4 
weeks of gestation according to NRC (2007). Treatments: MP60 = 60% of MP requirements, 
MP100 = 100% of MP requirements, MP140 = 140% of MP requirements. 
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Conclusion 
The sheep is a valuable model for the study of developmental programming mechanisms 
that are critical to a better understanding of the nutrition and prenatal muscle development 
relationship. The lack of genetic and genomic resources on the sheep has limited the power of 
proteomic analysis, impending progress in emerging areas of sheep pregnancy biology and 
advanced muscle research. Ovine fetal LM was sensitive to maternal MP supplementation during 
late gestation. Using 2D DIGE to compare the proteome of muscles that differ between 
treatment, numerous proteins were identified that may be useful in understanding the metabolism 
of developing fetal sheep muscle. Tubulin beta 5-chain, alpha-enolase, and phosphoglucomutase 
differed in relative abundance in the sarcoplasmic fraction of fetal LM from MP60 and MP100-
supplemented ewes. Creatine kinase and fructose-bisphosphate aldolase differed in relative 
abundance in the sarcoplasmic fraction of fetal LM from MP100 and MP140-supplemented 
ewes. The data presented in this study may influence current research on the series of genes 
expressed in the fetal ovine LM, which will strengthen annotation and assembly of the sheep 
genome. Notable, however, was our identification of many high abundant proteins. Using 2D-
DIGE on fetal muscle has proven to be a useful method, but alterations in preparation of the gel 
sample must be considered in order to look more closely at low abundant proteins that may have 
been masked during this experiment. 
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CHAPTER 4. OVERALL CONCLUSIONS AND FUTURE DIRECTIONS 
 Developmental programming research in ruminant livestock species has focused on 
altering overall caloric intake. Currently, little is known about how specific nutrient (e.g. protein, 
energy, amino acids, fatty acids, minerals, vitamins) supplementation during gestation influences 
fetal organ growth and skeletal muscle development. Providing supplemental protein during late 
gestation is crucial to maintenance of the dam and growth of the fetus. Altering a subset of 
maternal nutrients, while still providing an isocaloric diet has proved to have some beneficial 
effects with regard to fetal organ growth and skeletal muscle development. 
Fetal visceral organ growth was sensitive to maternal MP supplementation, enhancing 
small intestinal mass and perirenal fat content. Feeding isocaloric protein is important to fetal 
development, but demands further research into effects on postnatal growth. Additional 
investigation is also needed regarding maternal supplementation of isocaloric protein and its 
possible alterations to fetal skeletal muscle fiber type. Further understanding of metabolizable 
protein’s role in fetal development will allow for the design of supplementation schemes and 
altered management strategies to improve fetal growth efficiency, thereby improving the 
offspring’s health and performance. 
 
